{"service":"scrimed-strategic-platform-intelligence","status":"source-informed-strategy-coded","route":"/strategic-intelligence","apiRoute":"/api/strategic-intelligence","reviewedAt":"2026-06-27","boundary":"This layer translates public strategy signals into SCRIMED product architecture. It does not copy third-party products, assert partnerships, certify compliance, or authorize live clinical execution.","sourceCount":7,"patternCount":5,"roadmapCount":3,"executionBetCount":8,"executeNowBetCount":3,"thirtyDayBetCount":1,"sixtyDayBetCount":2,"ninetyDayBetCount":2,"decisionGateCount":6,"executionCommandCount":8,"criticalExecutionCommandCount":3,"thisWeekExecutionCommandCount":2,"thirtyDayExecutionCommandCount":3,"sixtyDayExecutionCommandCount":2,"ninetyDayExecutionCommandCount":1,"executionCommandProofRouteCount":32,"executionCommandBlockedExpansionCount":40,"executionCommandDecisionGateCount":6,"executionScorecardCount":8,"activeExecutionScorecardCount":3,"watchExecutionScorecardCount":3,"sequencedExecutionScorecardCount":2,"proofReadyExecutionScorecardCount":3,"proofBuildingExecutionScorecardCount":4,"externalReviewExecutionScorecardCount":1,"executionScorecardCurrentProofRouteCount":33,"executionScorecardMissingProofCount":24,"executionScorecardPromotionCriterionCount":31,"executionScorecardDemotionTriggerCount":32,"competitiveMarketIntelligenceStatus":"competitor-informed-build-map-active","competitiveMarketIntelligenceRoute":"/competitive-intelligence","competitiveMarketIntelligenceApiRoute":"/api/competitive-intelligence","competitorSourceCount":18,"competitorBuildPatternCount":5,"competitorInitiativeCount":5,"competitorProofMetricCount":25,"competitorBlockedClaimCount":20,"standards":["FHIR","HL7 v2","DICOM/DICOMweb","X12","C-CDA","LOINC","SNOMED CT","FHIR R4/R5","SMART on FHIR","DICOMweb","CPT/HCPCS","MCP","HL7","RxNorm","ICD-10","ICD-11","DICOM","HL7 v2 ORU","FHIR Device","IEEE 11073","IHE","CMS reporting concepts"],"agents":["Agent Commander","DocuTwin","CareExplain","Ambient Scribe","PayerIQ","Interoperability Agent","Clinical Intelligence Agent","Documentation Agent","Sanar AI","TrialCore","Imaging Agent","Operations Agent","Supply Chain Agent","Investor Agent","Revenue Integrity Agent","Governance Agent"],"routes":["/agents","/atlas","/observability","/agent-workspace","/healthcare-intelligence-os","/interoperability","/integrations","/workflows/contracts","/pilot-evidence","/trust","/audit","/memory","/workflows","/synthetic/fixtures","/sales-operations","/governance-packs","/pricing","/product"],"sources":[{"name":"NVIDIA Inception","url":"https://www.nvidia.com/en-us/startups/","observedPattern":"Startup acceleration combines technical training, developer tooling, cloud or partner offers, market reach, and investor ecosystem access.","scrimedInterpretation":"SCRIMED should maintain a partner and investor-readiness lane that turns product proof into ecosystem leverage without overstating commercial maturity."},{"name":"NVIDIA Healthcare and Life Sciences","url":"https://www.nvidia.com/en-us/industries/healthcare-life-sciences/","observedPattern":"Healthcare AI platforms span agents, imaging, medical devices, genomics, digital health, edge runtimes, and infrastructure for the full AI lifecycle.","scrimedInterpretation":"SCRIMED should treat Atlas and AgentOS as an AI-factory readiness layer: runtime routing, evidence, edge/sovereign deployment planning, and healthcare-specific workflow controls."},{"name":"Epic","url":"https://www.epic.com","observedPattern":"Healthcare software differentiates through patient-centered records, interoperability, operational efficiency, and measurable workflow outcomes.","scrimedInterpretation":"SCRIMED should sit beside EHRs as a governed intelligence and workflow layer, with FHIR/HL7/DICOM/X12 proof and no live writeback during synthetic pilots."},{"name":"AWS Health Care","url":"https://awshealthcare.co","observedPattern":"This source is a Dubai medical equipment supplier, not Amazon Web Services; it highlights equipment categories, quality posture, and regional healthcare supply pathways.","scrimedInterpretation":"SCRIMED should prepare a device, imaging, lab, and facility-equipment interoperability pathway for Middle East and global pilots while clearly separating supplier context from cloud strategy."},{"name":"Microsoft Copilot","url":"https://copilot.microsoft.com","observedPattern":"Copilot presents an assistant-style interaction model centered on user-directed prompts and responses.","scrimedInterpretation":"SCRIMED should keep agent experiences human-directed, role-aware, and review-gated rather than presenting autonomous clinical authority."},{"name":"OpenAI Developers","url":"https://developers.openai.com","observedPattern":"Developer platform surfaces APIs, agents, evals, guardrails, multimodal capabilities, realtime audio, demos, and MCP-based app extension patterns.","scrimedInterpretation":"SCRIMED should expose modular APIs, model-router abstraction, eval loops, guardrail surfaces, and MCP-compatible connectors for enterprise adoption."},{"name":"NVIDIA Technical Blog","url":"https://developer.nvidia.com/blog/","observedPattern":"Recent technical themes include AI factory operations, adaptive inference, accelerated genomics, reusable robotics workflows, simulation, and edge deployment.","scrimedInterpretation":"SCRIMED should measure throughput, latency, cost, evidence quality, and deployment portability across synthetic workflows before promoting any production execution."}],"patterns":[{"slug":"healthcare-ai-factory-readiness","title":"Healthcare AI Factory Readiness","priority":"platform","sourceNames":["NVIDIA Healthcare and Life Sciences","NVIDIA Technical Blog"],"productThesis":"Healthcare buyers need a governed operating layer that can run agents, evidence retrieval, model routing, and workflow validation across cloud, private cloud, edge, and sovereign settings.","scrimedImplementation":"Extend AgentOS, Atlas Intelligence Core, observability, and persistent workspaces into a deployment-readiness register for cost, latency, safety, evidence provenance, and portability.","routes":["/agents","/atlas","/observability","/agent-workspace","/healthcare-intelligence-os"],"agents":["Agent Commander","DocuTwin","CareExplain","Ambient Scribe","PayerIQ"],"interoperabilityStandards":["FHIR","HL7 v2","DICOM/DICOMweb","X12","C-CDA","LOINC","SNOMED CT"],"governanceControls":["model-router policy","human-review checkpoint","synthetic-only workload","runtime safety gate","sovereign deployment review"],"proofMetrics":["latency","cost-per-work-order","override rate","escalation rate","evidence completeness"],"blockedClaims":["production authorized","HIPAA certified","autonomous clinical execution"],"nextBuildStep":"Connect deployment-profile fixtures to buyer intake, protected workspace activation metadata, and synthetic throughput metrics."},{"slug":"patient-centered-interoperability-layer","title":"Patient-Centered Interoperability Layer","priority":"near-term","sourceNames":["Epic"],"productThesis":"The winning healthcare intelligence layer must improve fragmented workflows without displacing the clinical record of truth.","scrimedImplementation":"Keep SCRIMED as a sidecar intelligence fabric that reads synthetic fixtures, validates interoperability contracts, and blocks EHR writeback until customer-approved production connectors exist.","routes":["/interoperability","/integrations","/workflows/contracts","/pilot-evidence"],"agents":["Interoperability Agent","Clinical Intelligence Agent","Documentation Agent"],"interoperabilityStandards":["FHIR R4/R5","SMART on FHIR","HL7 v2","DICOMweb","X12","CPT/HCPCS"],"governanceControls":["connector contract","fixture validation","no-live-writeback gate","audit trail","licensed reviewer escalation"],"proofMetrics":["fixture pass rate","mapping completeness","source attribution coverage","workflow friction reduced"],"blockedClaims":["EHR-certified integration","live patient sync","clinical decision authorization"],"nextBuildStep":"Promote interoperability conformance outputs into buyer proof packets and protected workspace activation evidence."},{"slug":"evidence-backed-agent-workforce","title":"Evidence-Backed Agent Workforce","priority":"near-term","sourceNames":["OpenAI Developers","NVIDIA Healthcare and Life Sciences","Microsoft Copilot"],"productThesis":"Enterprise healthcare agents must be specialized, tool-aware, observable, and easy for humans to direct and review.","scrimedImplementation":"Use AgentOS and TrustOS as the shared orchestration, verification, audit, and human-approval layer for Sanar AI, DocuTwin, CareExplain, Ambient Scribe, TrialCore, and PayerIQ.","routes":["/agents","/trust","/audit","/memory","/workflows","/agent-workspace"],"agents":["Sanar AI","DocuTwin","CareExplain","Ambient Scribe","TrialCore","PayerIQ"],"interoperabilityStandards":["MCP","FHIR","HL7","LOINC","RxNorm","ICD-10","ICD-11"],"governanceControls":["TrustQA score","source attribution","reviewer status","model/provider log","prompt/tool audit"],"proofMetrics":["trust score","completion rate","review time","rework rate","citation coverage"],"blockedClaims":["clinician replacement","autonomous diagnosis","unreviewed treatment plan"],"nextBuildStep":"Add multi-model provider profiles and fallback simulation to AgentOS task records."},{"slug":"device-edge-and-facility-integration-pathway","title":"Device, Edge, and Facility Integration Pathway","priority":"mid-term","sourceNames":["AWS Health Care","NVIDIA Healthcare and Life Sciences"],"productThesis":"Global healthcare intelligence must eventually connect operational data from imaging, labs, devices, facility systems, and regional equipment ecosystems.","scrimedImplementation":"Add a device-readiness pathway for DICOM imaging, lab equipment, patient-monitor data, medical gas/facility signals, and supplier/vendor context using synthetic connector fixtures first.","routes":["/integrations","/interoperability","/synthetic/fixtures","/observability"],"agents":["Imaging Agent","Interoperability Agent","Operations Agent","Supply Chain Agent"],"interoperabilityStandards":["DICOM","DICOMweb","HL7 v2 ORU","FHIR Device","IEEE 11073","IHE"],"governanceControls":["synthetic device fixture only","vendor-source attribution","edge deployment review","facility safety exclusion","no device command execution"],"proofMetrics":["device fixture coverage","data-quality issues surfaced","mapping accuracy","review escalations"],"blockedClaims":["medical device control","diagnostic imaging interpretation","facility automation authorized"],"nextBuildStep":"Create synthetic device and imaging fixture scenarios for monitor, lab, DICOM, and facility-equipment workflows."},{"slug":"outcome-proof-and-commercial-channel","title":"Outcome Proof and Commercial Channel","priority":"mid-term","sourceNames":["Epic","NVIDIA Inception","NVIDIA Technical Blog"],"productThesis":"A trillion-dollar healthcare infrastructure company compounds through measurable outcomes, trusted references, partner access, and investor-ready proof surfaces.","scrimedImplementation":"Use Sales Operations, Pilot Evidence, Governance Packs, and Investor Agent proof to track buyer outcomes, partner readiness, pricing fit, and activation gates.","routes":["/sales-operations","/pilot-evidence","/governance-packs","/pricing","/product"],"agents":["Investor Agent","Revenue Integrity Agent","Governance Agent","Operations Agent"],"interoperabilityStandards":["FHIR","X12","HL7","CMS reporting concepts"],"governanceControls":["approved claims register","non-binding proposal","proof-packet audit","pricing boundary","external approval tracker"],"proofMetrics":["time saved","denial-risk surfaced","revenue leakage identified","conversion stage","sales cycle risk"],"blockedClaims":["guaranteed savings","guaranteed reimbursement","customer-certified compliance"],"nextBuildStep":"Connect activation governance ledger events to sales opportunities and investor proof packets."}],"roadmap":[{"phase":"Phase 1","objective":"Turn source-informed strategy into inspectable product architecture.","codedFoundation":"Strategic intelligence summary, API, page, and product console proof link.","nextBuild":"Tie strategic patterns to deployment-profile fixtures and protected workspace evidence."},{"phase":"Phase 2","objective":"Operationalize AI factory and interoperability readiness.","codedFoundation":"AgentOS, Atlas Intelligence Core, interoperability conformance, observability, and governance packs.","nextBuild":"Connect cloud/private/edge/sovereign deployment profiles with buyer intake, workspace activation, and proof-packet evidence."},{"phase":"Phase 3","objective":"Advance device, imaging, payer, and EHR-sidecar pilots.","codedFoundation":"Integration fixtures, DICOM/FHIR/HL7/X12 standards registry, and protected pilot workspaces.","nextBuild":"Create device and facility integration demo fixtures with no live control or diagnostic claims."}],"executionBets":[{"slug":"buyer-conversion-compression","name":"Buyer Conversion Compression","horizon":"now","thesis":"SCRIMED wins faster when every visitor can move from problem to package to no-PHI proof without reading the whole operating map.","buildMotion":"Keep homepage, Product Console, Offerings, Pricing, Demos, Pilots, Client Onboarding, and Company Assessment aligned around assessment, synthetic pilot, protected enterprise pilot, license, and retainer paths.","sellMotion":"Use one buyer pain, one recommended package, one proof route, one price posture, and one retained boundary in every demo or discovery call.","proofMetric":"Demo-to-pilot path selected before custom scope expands.","stopCondition":"Buyer cannot identify the next package or asks for custom work before no-PHI intake is complete.","owners":["Product Console","Revenue Operations","Client Onboarding","Deal Desk"],"proofRoutes":["/product","/offerings","/pricing","/client-onboarding","/pilot-demo-commercial-readiness"],"retainedBoundary":"Conversion compression is not a signed quote, contract, procurement approval, ROI guarantee, or revenue guarantee."},{"slug":"proof-before-production-risk","name":"Proof Before Production Risk","horizon":"now","thesis":"The safest strategic wedge is to show operational value with synthetic, source-attributed, no-PHI proof before protected data or live clinical authority enters scope.","buildMotion":"Turn synthetic demos, pilot evidence, Claim Guard, health-record safety checks, and protected proof release into a repeatable no-PHI evaluation ladder.","sellMotion":"Lead with no-PHI workflow assessment, synthetic pilot, trust diligence, and protected enterprise pilot as sequential buyer decisions.","proofMetric":"Synthetic proof packet exists before protected proof or integration conversation expands.","stopCondition":"Buyer requests PHI, live records, production credentials, writeback, or customer-specific proof without approval chain.","owners":["TrustOS","Pilot Evidence","Health Records Safety","Buyer Diligence"],"proofRoutes":["/demos","/pilots","/pilot-evidence","/health-records","/qa-buyer-proof-release"],"retainedBoundary":"No-PHI proof is not PHI authority, clinical validation, customer permission, production connector approval, or live-care authorization."},{"slug":"trust-as-procurement-advantage","name":"Trust As Procurement Advantage","horizon":"now","thesis":"SCRIMED should make governance, limitations, claim controls, and boundary escalation feel like reasons to buy, not reasons to hesitate.","buildMotion":"Surface TrustOS, Claim Guard, Boundary Resolution, Limitations Workarounds, Continuous Review, and Operational Efficiency near buyer CTAs and diligence paths.","sellMotion":"Position visible hard stops, human review, protected release, and no-overclaim language as procurement confidence accelerators.","proofMetric":"Every buyer-facing offer points to a trust, claim, boundary, or review proof route.","stopCondition":"Copy implies certification, security assurance, live clinical authority, public SLA, revenue guarantee, or autonomous remediation.","owners":["TrustOS","Legal Ops","Security","Claims Governance"],"proofRoutes":["/trust-center","/qa-claim-guard","/boundary-resolution","/limitations-workarounds","/continuous-review-audit"],"retainedBoundary":"Trust positioning is not legal advice, certification, security assurance, managed SOC/MDR coverage, or attack-proof guarantee."},{"slug":"interoperability-sidecar-wedge","name":"Interoperability Sidecar Wedge","horizon":"30-days","thesis":"SCRIMED can compete beside EHR, payer, and RCM incumbents by being the safer sidecar for source-attributed workflow intelligence.","buildMotion":"Package standards maps, no-PHI fixtures, synthetic extraction, patient-safety lint, connector questionnaires, and live-data gate lists into a readiness sprint.","sellMotion":"Sell interoperability readiness before production integration, especially to health-system, payer, and clinic operators who need clarity before vendor risk review.","proofMetric":"Standards map and no-PHI fixture set exist before any live connector conversation.","stopCondition":"Integration discussion requires live PHI, patient matching, payer submission, EHR writeback, or device/facility control.","owners":["Interoperability","Health Records Safety","Clinical Governance","Privacy"],"proofRoutes":["/interoperability","/health-records","/clinical-production-readiness","/clinical-authority-readiness"],"retainedBoundary":"Interoperability wedge is not production integration, PHI authority, EHR writeback approval, payer submission approval, or clinical authority."},{"slug":"enterprise-operating-layer-license","name":"Enterprise Operating-Layer License","horizon":"60-days","thesis":"The long-term value is not a single workflow demo; it is a governed healthcare intelligence operating layer with APIs, agents, evidence, service delivery, and trust controls.","buildMotion":"Align Platform Power, Enterprise Scalability, Service Delivery, Product Console, AgentOS, TrustOS, and Operational Efficiency into an annual license plus services motion.","sellMotion":"Convert successful assessment or synthetic pilot buyers into operating-layer license, implementation work order, and governed review retainer.","proofMetric":"Buyer can inspect API/UI/AI controls, scale boundaries, service work orders, and trust gates before license proposal.","stopCondition":"Buyer requires public API SLA, managed-service commitment, production model routing, PHI, or unsupported scale equivalence.","owners":["Platform","Product Console","Service Delivery","Enterprise Scalability","Finance"],"proofRoutes":["/platform-power","/enterprise-scalability","/service-delivery","/operational-efficiency","/agents"],"retainedBoundary":"Operating-layer licensing is not EHR replacement, public API SLA, production hosting approval, PHI authority, or live autonomous AI."},{"slug":"capital-and-partner-proof-room","name":"Capital And Partner Proof Room","horizon":"60-days","thesis":"Investors and strategic partners need a disciplined evidence room that shows traction logic without securities, valuation, customer, or revenue overclaims.","buildMotion":"Connect Company Assessment, Capital Vitality, Investor Audience Readiness, Growth Engine, Public Market Readiness, and protected proof rooms into one diligence packet map.","sellMotion":"Use audience-specific packets for angels, private investors, corporate strategics, faith-based clinic sponsors, payers, health systems, and public-sector partners.","proofMetric":"Each audience packet includes current capability, proof route, revenue motion, blocked claims, and qualified-review needs.","stopCondition":"Packet implies securities offering, solicitation, valuation assurance, audited financials, customer proof, reimbursement certainty, or revenue guarantee.","owners":["Founder","Capital Operations","Finance","Legal Ops","Claim Guard"],"proofRoutes":["/company-assessment","/capital-vitality","/investor-audience-readiness","/growth-engine","/public-market-readiness"],"retainedBoundary":"Capital proof is not investment advice, solicitation, securities material, valuation assurance, audited financial reporting, or revenue guarantee."},{"slug":"global-approval-runway","name":"Global Approval Runway","horizon":"90-days","thesis":"Global growth requires pre-structured evidence, regional review gates, privacy/AI/cyber readiness, and certification preparation before market claims expand.","buildMotion":"Route global buyer asks through Global Certification Readiness, Approvals Readiness, Global Reach, Competitive Defense, Health Records, and Clinical Production Readiness.","sellMotion":"Offer region-specific readiness planning and no-PHI evaluation while blocking approval, certification, residency, public-sector, reimbursement, or live-care claims.","proofMetric":"Each target region has a readiness pack with reviewer owner, evidence class, blocked claims, and next action.","stopCondition":"Public language suggests regional regulatory approval, certification, public procurement approval, data residency approval, or clinical deployment authority.","owners":["Global Readiness","Legal Ops","Privacy","Security","Clinical Governance"],"proofRoutes":["/global-certification-readiness","/approvals-readiness","/global-reach","/competitive-defense","/clinical-production-readiness"],"retainedBoundary":"Global runway is not legal advice, certification, regional approval, procurement approval, PHI authority, or live clinical deployment."},{"slug":"clinical-production-gate-discipline","name":"Clinical Production Gate Discipline","horizon":"90-days","thesis":"SCRIMED should keep selling current no-PHI capabilities while making the path to clinical production explicit, incomplete, and owner-driven.","buildMotion":"Keep Clinical Production Readiness, Clinical Authority Readiness, Health Records, protected workspaces, QA gates, and approval ladders synchronized.","sellMotion":"Use current safe offers for revenue while openly showing what remains before PHI, live care, connectors, regulated clinical claims, or customer go-live.","proofMetric":"Clinical production readiness tasks have owners, missing evidence, dependencies, current safe use, and retained boundary.","stopCondition":"Any external artifact implies clinical production readiness, FDA/ONC certification, HIPAA assurance, PHI processing, customer go-live, or live-care authority.","owners":["Clinical Governance","Privacy","Security","Product","Release Steward"],"proofRoutes":["/clinical-production-readiness","/clinical-authority-readiness","/health-records","/approvals-readiness","/pilot-workspace/access"],"retainedBoundary":"Clinical gate discipline is not legal advice, regulatory approval, HIPAA assurance, connector approval, PHI authority, or live-care authorization."}],"decisionGates":[{"slug":"no-phi-proof-gate","gate":"No-PHI proof gate","trigger":"Buyer asks for data, record extraction, pilot proof, diligence material, or workflow evaluation.","decisionOwner":"TrustOS + Health Records Safety","requiredEvidence":["synthetic fixture","source attribution","no-PHI intake","blocked live-data claim"],"allowIf":"Proof can be produced with synthetic or metadata-only material and current-state language.","blockIf":"PHI, identifiers, production credentials, live endpoints, or patient-impacting action is required.","proofRoutes":["/health-records","/pilot-evidence","/qa-claim-guard"],"retainedBoundary":"No-PHI proof gate does not authorize PHI, production connectors, or clinical action."},{"slug":"buyer-proof-release-gate","gate":"Protected buyer proof release gate","trigger":"Customer-specific proof, protected packet, diligence export, or buyer room material is requested.","decisionOwner":"Buyer Diligence + Release Steward","requiredEvidence":["AAL2 workspace","reviewer signoff","release decision","recipient control","Claim Guard language"],"allowIf":"Release chain is complete and external language is claim-guarded.","blockIf":"Recipient, release authority, reviewer signoff, access log, or current-state boundary is missing.","proofRoutes":["/qa-buyer-proof-release","/buyer-release-control-run","/pilot-workspace/access"],"retainedBoundary":"Buyer proof release gate does not create customer permission or public proof authority."},{"slug":"deal-desk-margin-gate","gate":"Deal desk and margin gate","trigger":"Proposal, paid pilot, renewal, discount, strategic partnership, enterprise license, or custom work request appears.","decisionOwner":"Finance + Deal Desk + Legal Ops","requiredEvidence":["package","scope","price floor","billing trigger","margin review","blocked claims"],"allowIf":"Scope, margin, billing, contract authority, and no-guarantee language are reviewed.","blockIf":"Unpriced custom work, unsupported ROI/revenue language, payment-term uncertainty, or tax/accounting exception exists.","proofRoutes":["/enterprise-business-ops","/service-delivery","/capital-vitality"],"retainedBoundary":"Deal desk gate is not legal, accounting, tax, audit, securities, valuation, revenue, or profit assurance."},{"slug":"clinical-production-gate","gate":"Clinical production and connector gate","trigger":"PHI, live clinical care, EHR/HIE/payer connector, patient matching, payer submission, writeback, or regulated clinical claim is requested.","decisionOwner":"Clinical Governance + Privacy + Security + Regional Counsel","requiredEvidence":["clinical production task status","qualified review","customer authority","security/privacy gate","connector acceptance"],"allowIf":"All required clinical production tasks, approvals, and customer authority are complete.","blockIf":"Any PHI, live-care, connector, certification, regional, or customer go-live evidence is missing.","proofRoutes":["/clinical-production-readiness","/clinical-authority-readiness","/approvals-readiness","/health-records"],"retainedBoundary":"Clinical production gate is not approval, certification, PHI authority, connector approval, or live-care authorization."},{"slug":"platform-scale-sla-gate","gate":"Platform scale and SLA gate","trigger":"Public API, production model routing, support tier, uptime, regional deployment, managed service, or scale-equivalence language is proposed.","decisionOwner":"Platform + Enterprise Scalability + Legal Ops","requiredEvidence":["capacity assumption","queue/backpressure plan","incident path","support tier","cost guardrail","contract review"],"allowIf":"Language remains readiness-only or exact commitments are contract-reviewed and funded.","blockIf":"Public API SLA, uptime guarantee, managed service, data residency, or trillion-scale parity is implied without authority.","proofRoutes":["/platform-power","/enterprise-scalability","/service-reliability","/operational-efficiency"],"retainedBoundary":"Scale gate is not public API SLA, uptime guarantee, hosting approval, managed-service commitment, or scale-equivalence proof."},{"slug":"public-claims-and-investor-gate","gate":"Public claims and investor gate","trigger":"Website copy, sales deck, investor packet, market comparison, press language, or audience packet is updated.","decisionOwner":"Claim Guard + Legal Ops + Capital Operations","requiredEvidence":["source route","current capability","blocked claims","qualified review need","approved no-authority text"],"allowIf":"Language stays current-state, evidence-backed, and no-authority bounded.","blockIf":"Copy implies securities material, solicitation, valuation, audited financials, certification, customer proof, ROI, revenue, or legal conclusion.","proofRoutes":["/qa-claim-guard","/investor-audience-readiness","/company-assessment","/competitive-defense"],"retainedBoundary":"Claims gate is not legal advice, securities material, investment advice, valuation assurance, audited financial reporting, or certification."}],"executionCommands":[{"slug":"customer-facing-conversion-command","lane":"Customer-Facing Conversion","horizon":"this-week","priority":"critical","objective":"Turn qualified site traffic into a selected no-PHI assessment, demo, pilot, pricing path, or buyer conversation without forcing prospects through the full operating map.","executionMove":"Keep homepage, Product Console, Market Intelligence, Offerings, Pricing, Client Onboarding, and Pilot Demo Commercial Readiness aligned around one recommended buyer path per audience.","commercialOutcome":"Shorter path from interest to paid readiness assessment, synthetic pilot, or protected enterprise pilot.","operatingCadence":"Daily CTA and copy review during launch pushes; weekly proof-route review before investor, buyer, or clinic outreach.","owners":["Founder","Product marketing","Revenue operations","Client onboarding"],"proofRoutes":["/product","/competitive-intelligence","/offerings","/pricing","/client-onboarding"],"requiredProof":["audience-specific sales message","recommended package","price band or price posture","proof route","retained boundary"],"dependencies":["competitive target-audience strategy","pilot demo commercial readiness","client onboarding communications","claim guard review"],"decisionGateSlugs":["public-claims-and-investor-gate","deal-desk-margin-gate"],"blockedExpansion":["custom scope before no-PHI intake","ROI guarantee","signed quote language","customer-proof claim"],"revenueMotion":"Convert visitors into paid assessment, demo workshop, synthetic pilot, or enterprise readiness sprint.","successMetric":"Every qualified buyer path resolves to one next action, one package, one proof route, and one boundary.","nextAction":"Review top CTAs and buyer packets weekly against the competitive target-audience strategy and Pilot Demo Commercial Readiness price bands.","retainedBoundary":"Conversion command is not a contract, procurement approval, legal advice, ROI guarantee, revenue guarantee, or customer permission."},{"slug":"no-phi-proof-engine-command","lane":"No-PHI Proof Engine","horizon":"this-week","priority":"critical","objective":"Make proof-before-production the default execution path for every buyer, investor, clinic, and partner conversation.","executionMove":"Route demos, synthetic scenarios, health-record extraction planning, QA evidence, and buyer proof release into one no-PHI proof ladder.","commercialOutcome":"Buyers can purchase useful evaluation work now while clinical production, PHI, and connector authority remain explicitly gated.","operatingCadence":"Run proof-ladder checks before every pilot proposal, demo recap, diligence packet, and protected workspace promotion.","owners":["TrustOS","QA evidence","Health records safety","Pilot evidence","Release steward"],"proofRoutes":["/demos","/pilot-evidence","/health-records","/qa-evidence","/qa-buyer-proof-release"],"requiredProof":["synthetic fixture","source attribution","human-review checkpoint","blocked live-data claim","proof-packet route"],"dependencies":["clinical production readiness","health records safety exchange","QA claim guard","buyer release control"],"decisionGateSlugs":["no-phi-proof-gate","buyer-proof-release-gate","clinical-production-gate"],"blockedExpansion":["PHI upload","patient identifier intake","production credentials","EHR writeback","payer submission"],"revenueMotion":"Package no-PHI proof work as paid readiness assessment, synthetic pilot, trust diligence, and protected pilot setup.","successMetric":"Every external proof artifact declares synthetic/no-PHI status before value, metric, or roadmap language.","nextAction":"Attach a no-PHI proof ladder checklist to each demo-to-pilot packet and Product Readiness Brief section.","retainedBoundary":"No-PHI proof command does not authorize PHI processing, clinical validation, customer proof release, production connectors, or live care."},{"slug":"deal-desk-margin-command","lane":"Deal Desk and Margin","horizon":"30-days","priority":"critical","objective":"Protect profit margin and enterprise credibility before proposals, pricing exceptions, custom service work, or strategic partnership conversations expand.","executionMove":"Require Enterprise Business Ops, Service Delivery, Growth Engine, Capital Vitality, and pricing paths before proposal release or custom work expansion.","commercialOutcome":"Fewer underpriced pilots, clearer enterprise terms, stronger cash discipline, and cleaner investor diligence.","operatingCadence":"Deal desk pass before every proposal; weekly margin exception review; monthly revenue-recognition and billing-readiness review.","owners":["Deal desk","Finance","Legal operations","Service delivery","Founder"],"proofRoutes":["/enterprise-business-ops","/service-delivery","/growth-engine","/capital-vitality","/pricing"],"requiredProof":["package scope","price floor","acceptance criteria","billing trigger","margin review","blocked claims"],"dependencies":["product and services portfolio","client onboarding","enterprise scalability","legal/accounting/tax qualified review when needed"],"decisionGateSlugs":["deal-desk-margin-gate","platform-scale-sla-gate","public-claims-and-investor-gate"],"blockedExpansion":["unpriced custom work","unsupported discounting","profit guarantee","reimbursement guarantee","managed-service commitment"],"revenueMotion":"Move from founder-led custom work to packaged assessments, pilots, readiness sprints, operating-layer licenses, and retained governance services.","successMetric":"Every external proposal has scope, price posture, acceptance criteria, margin boundary, and blocked claims.","nextAction":"Make deal desk review mandatory in every pilot, enterprise, investor-sponsored clinic, and strategic partner packet.","retainedBoundary":"Deal desk command is not legal advice, tax advice, accounting advice, audited financial reporting, contract approval, revenue assurance, or profit assurance."},{"slug":"buyer-proof-release-command","lane":"Buyer Proof Release","horizon":"30-days","priority":"high","objective":"Convert synthetic and protected proof into controlled buyer-diligence assets without leaking customer proof, confidential artifacts, PHI, or unapproved claims.","executionMove":"Use protected workspaces, QA Buyer Proof Release, Buyer Release Control, reviewer signoffs, lockbox controls, and evidence-room routing before external sharing.","commercialOutcome":"Higher enterprise trust with safer diligence sharing, cleaner procurement responses, and fewer approval surprises.","operatingCadence":"Release-control review before each buyer diligence packet; weekly open-blocker review for protected evidence assets.","owners":["Release steward","Buyer diligence","Legal operations","Security","Customer sponsor"],"proofRoutes":["/pilot-workspace/access","/qa-buyer-proof-release","/buyer-release-control-run","/trust-center"],"requiredProof":["AAL2 workspace","release decision","reviewer signoff","recipient control","claim-guarded language","access-log reconciliation path"],"dependencies":["customer permission reference","external approval evidence","provider security review metadata","protected procurement evidence registry"],"decisionGateSlugs":["buyer-proof-release-gate","public-claims-and-investor-gate"],"blockedExpansion":["public customer proof","unapproved export","signed approval storage","recipient list storage","confidential artifact upload"],"revenueMotion":"Use controlled diligence as an enterprise sales accelerator after paid pilot setup or protected buyer-room activation.","successMetric":"Every buyer-specific proof asset has release status, reviewer owner, recipient boundary, and blocked export posture.","nextAction":"Require Buyer Release Control metadata before referencing protected proof in sales, investor, or strategic partner conversations.","retainedBoundary":"Buyer proof release command is not customer permission, public release approval, legal approval, security certification, PHI authority, or clinical authority."},{"slug":"interoperability-health-records-command","lane":"Interoperability and Health Records","horizon":"30-days","priority":"high","objective":"Make interoperability a sellable sidecar readiness sprint while keeping production EHR, HIE, payer, imaging, and device authority blocked.","executionMove":"Package standards maps, synthetic fixture validation, health-record extraction planning, connector trust labels, safety checks, and live-use blockers.","commercialOutcome":"Health systems, payers, clinics, and technical reviewers can buy integration readiness before live connector risk enters scope.","operatingCadence":"Connector readiness review per buyer opportunity; monthly standards-map refresh; live-use blocker review before any technical claim expands.","owners":["Interoperability","Health records safety","Security","Clinical governance","Implementation lead"],"proofRoutes":["/interoperability","/integrations","/health-records","/platform-power","/clinical-production-readiness"],"requiredProof":["standards map","synthetic fixture","safety check","connector status label","live-use blocker"],"dependencies":["customer connector approval","BAA/DPA readiness","privacy/security review","clinical authority readiness"],"decisionGateSlugs":["no-phi-proof-gate","clinical-production-gate","platform-scale-sla-gate"],"blockedExpansion":["certified EHR integration","live patient sync","patient matching","payer submission","device command execution"],"revenueMotion":"Sell interoperability readiness sprint, health-record extraction planning, and technical buyer diligence as paid services.","successMetric":"Every connector conversation has a visible synthetic-ready, contract-ready, protected-gated, or blocked-live-use label.","nextAction":"Promote connector trust labels into pilot and technical sales packets for FHIR, HL7, X12, DICOM, SMART, MCP, and health-record extraction.","retainedBoundary":"Interoperability command is not production connector approval, PHI authority, EHR writeback approval, payer submission approval, device control, or clinical authority."},{"slug":"enterprise-operating-layer-command","lane":"Enterprise Operating Layer","horizon":"60-days","priority":"high","objective":"Turn SCRIMED from a collection of readiness pages into an inspectable healthcare intelligence operating-layer license plus services motion.","executionMove":"Align Platform Power, Enterprise Scalability, Service Delivery, AgentOS, Atlas, TrustOS, Operational Efficiency, and Product Console into one license-ready packet.","commercialOutcome":"Creates a higher-margin enterprise path after assessments and pilots prove buyer value.","operatingCadence":"Biweekly platform readiness review; monthly enterprise package review; proposal gate before annual license language.","owners":["Platform","Product","Enterprise scalability","Service delivery","Finance"],"proofRoutes":["/platform-power","/enterprise-scalability","/service-delivery","/agents","/trust-os","/product"],"requiredProof":["API/UI/AI controls","scale boundaries","service work order","support boundary","cost guardrail","human approval gate"],"dependencies":["SLO/SLA readiness","support model","runtime observability","model routing approval","production tenancy strategy"],"decisionGateSlugs":["platform-scale-sla-gate","deal-desk-margin-gate","clinical-production-gate"],"blockedExpansion":["public API SLA","managed-service coverage","production model routing","trillion-scale equivalence","PHI processing"],"revenueMotion":"Annual platform license plus implementation work orders, governance retainer, and paid scale-readiness reviews.","successMetric":"Enterprise buyer can inspect license scope, platform controls, service work, support boundary, and blocked claims before proposal.","nextAction":"Create a license-readiness packet that maps Product Console proof counts to operating-layer license scope and service-delivery work orders.","retainedBoundary":"Enterprise operating-layer command is not EHR replacement, public API SLA, managed-service commitment, production model-routing approval, PHI authority, or live autonomous AI."},{"slug":"capital-partner-diligence-command","lane":"Capital and Partner Diligence","horizon":"60-days","priority":"high","objective":"Prepare investor, clinic sponsor, corporate strategic, payer, health-system, and partner conversations with evidence-rich packets that do not become securities or valuation materials.","executionMove":"Connect Company Assessment, Investor Audience Readiness, Capital Vitality, Growth Engine, Competitive Intelligence, Public Market Readiness, and protected evidence rooms.","commercialOutcome":"More credible fundraising, sponsorship, strategic-partner, and enterprise conversations without unsafe financial or customer claims.","operatingCadence":"Packet review before every capital or strategic conversation; monthly moat and milestone refresh; claim-guard pass before deck release.","owners":["Founder","Capital operations","Finance","Legal operations","Product strategy"],"proofRoutes":["/company-assessment","/investor-audience-readiness","/capital-vitality","/growth-engine","/public-market-readiness","/competitive-intelligence"],"requiredProof":["current capability","moat evidence","revenue motion","milestone","blocked claims","qualified-review need"],"dependencies":["audience-specific packet","deal desk review","finance methodology","public-market claim controls"],"decisionGateSlugs":["public-claims-and-investor-gate","deal-desk-margin-gate","buyer-proof-release-gate"],"blockedExpansion":["securities offering","solicitation","valuation assurance","audited financials","acquisition implication","customer revenue guarantee"],"revenueMotion":"Use readiness packets to convert interest into assessments, pilot sponsorships, strategic exploration, and enterprise partner diligence.","successMetric":"Each audience packet separates approved proof, readiness work, open gaps, blocked claims, and next investable milestone.","nextAction":"Refresh investor and strategic packets after every deployed capability release with claim-guarded proof and no-securities boundaries.","retainedBoundary":"Capital and partner diligence command is not investment advice, securities material, solicitation, valuation assurance, audited financial reporting, tax advice, or revenue guarantee."},{"slug":"clinical-global-approval-command","lane":"Clinical and Global Approval Runway","horizon":"90-days","priority":"sequenced","objective":"Keep domestic and global production readiness explicit while SCRIMED monetizes current no-PHI capabilities and builds evidence for future approval work.","executionMove":"Synchronize Clinical Production Readiness, Clinical Authority Readiness, Approvals Readiness, Global Certification Readiness, Global Reach, Health Records, and Continuous Review.","commercialOutcome":"Credible global and clinical conversations without claiming approval before external review, customer authority, or certification evidence exists.","operatingCadence":"Monthly clinical/global readiness review; region-specific packet review before external outreach; immediate Claim Guard escalation for approval language.","owners":["Clinical governance","Privacy","Security","Regional counsel","Global readiness"],"proofRoutes":["/clinical-production-readiness","/clinical-authority-readiness","/approvals-readiness","/global-certification-readiness","/global-reach","/continuous-review-audit"],"requiredProof":["clinical production task status","approval track","regional evidence class","external reviewer owner","blocked public claim"],"dependencies":["qualified legal/regulatory review","security certification roadmap","customer authority","regional privacy review","clinical validation plan"],"decisionGateSlugs":["clinical-production-gate","public-claims-and-investor-gate","no-phi-proof-gate"],"blockedExpansion":["FDA clearance","ONC certification","HIPAA assurance","EU AI Act conformity","GDPR assurance","live clinical deployment"],"revenueMotion":"Sell readiness planning, no-PHI evaluation, certification preparation, and regional partner discovery while production approval remains gated.","successMetric":"Every clinical or global opportunity has a region/use-case pack, approval blocker list, reviewer owner, and safe current offer.","nextAction":"Use clinical/global readiness reviews to prioritize which approval packets deserve qualified external counsel or auditor engagement first.","retainedBoundary":"Clinical/global approval command is not legal advice, regulatory approval, HIPAA assurance, certification, regional approval, PHI authority, or live clinical care."}],"executionCommandProofRoutes":["/product","/competitive-intelligence","/offerings","/pricing","/client-onboarding","/demos","/pilot-evidence","/health-records","/qa-evidence","/qa-buyer-proof-release","/enterprise-business-ops","/service-delivery","/growth-engine","/capital-vitality","/pilot-workspace/access","/buyer-release-control-run","/trust-center","/interoperability","/integrations","/platform-power","/clinical-production-readiness","/enterprise-scalability","/agents","/trust-os","/company-assessment","/investor-audience-readiness","/public-market-readiness","/clinical-authority-readiness","/approvals-readiness","/global-certification-readiness","/global-reach","/continuous-review-audit"],"executionCommandBlockedExpansions":["custom scope before no-PHI intake","ROI guarantee","signed quote language","customer-proof claim","PHI upload","patient identifier intake","production credentials","EHR writeback","payer submission","unpriced custom work","unsupported discounting","profit guarantee","reimbursement guarantee","managed-service commitment","public customer proof","unapproved export","signed approval storage","recipient list storage","confidential artifact upload","certified EHR integration","live patient sync","patient matching","device command execution","public API SLA","managed-service coverage","production model routing","trillion-scale equivalence","PHI processing","securities offering","solicitation","valuation assurance","audited financials","acquisition implication","customer revenue guarantee","FDA clearance","ONC certification","HIPAA assurance","EU AI Act conformity","GDPR assurance","live clinical deployment"],"executionCommandDecisionGateSlugs":["public-claims-and-investor-gate","deal-desk-margin-gate","no-phi-proof-gate","buyer-proof-release-gate","clinical-production-gate","platform-scale-sla-gate"],"executionScorecards":[{"commandSlug":"customer-facing-conversion-command","commandLane":"Customer-Facing Conversion","scoreState":"active","evidenceState":"proof-ready","strategicSignal":"Public routes already expose buyer pathways, competitive audience strategy, offerings, pricing, onboarding, and pilot-commercial readiness.","currentProof":["/product","/competitive-intelligence","/offerings","/pricing","/client-onboarding","/pilot-demo-commercial-readiness"],"missingProof":["weekly CTA review artifact","buyer-path analytics export","deal-source conversion cohort"],"leadingIndicator":"Qualified visitor can identify a next package, proof route, and boundary without a custom discovery detour.","laggingIndicator":"Paid assessment, demo workshop, synthetic pilot, or enterprise readiness sprint is selected before custom scope expands.","nextCheckpoint":"Review homepage, Product Console, Competitive Intelligence, Offerings, Pricing, and Client Onboarding copy against the target-audience strategy.","escalationPath":"Product marketing -> Claim Guard -> Deal Desk when a CTA implies ROI, customer proof, quote, or procurement authority.","promotionCriteria":["each target audience has one recommended offer path","price posture or band is visible","CTA routes to no-PHI intake or onboarding","blocked claims are visible before proposal language"],"demotionTriggers":["custom scope is requested before no-PHI intake","buyer cannot identify next step","CTA implies signed quote","ROI or customer-proof language appears without review"],"retainedBoundary":"Conversion scorecard is not a signed quote, contract, procurement approval, customer permission, ROI guarantee, or revenue guarantee."},{"commandSlug":"no-phi-proof-engine-command","commandLane":"No-PHI Proof Engine","scoreState":"active","evidenceState":"proof-ready","strategicSignal":"Demos, pilot evidence, health-record safety, QA evidence, and proof-release controls already keep no-PHI proof ahead of production requests.","currentProof":["/demos","/pilot-evidence","/health-records","/qa-evidence","/qa-buyer-proof-release"],"missingProof":["buyer-specific no-PHI proof ladder checklist","demo-to-pilot proof-packet template","approved proof-language registry for each demo"],"leadingIndicator":"Every proof request is classified as synthetic, metadata-only, protected, or blocked before artifacts are shared.","laggingIndicator":"External proof packets retain no-PHI status, source attribution, human review, and blocked live-data claims.","nextCheckpoint":"Attach the no-PHI proof ladder to every demo recap, pilot proposal, diligence packet, and protected workspace promotion.","escalationPath":"TrustOS -> Health Records Safety -> Clinical Production Readiness when a buyer asks for PHI, identifiers, credentials, writeback, or payer submission.","promotionCriteria":["synthetic fixture exists","source attribution exists","human-review checkpoint is named","live-data blocker is declared"],"demotionTriggers":["PHI upload requested","patient identifier intake appears","production credentials requested","EHR writeback or payer submission enters scope"],"retainedBoundary":"No-PHI proof scorecard does not authorize PHI processing, customer proof release, clinical validation, production connectors, or live clinical care."},{"commandSlug":"deal-desk-margin-command","commandLane":"Deal Desk and Margin","scoreState":"watch","evidenceState":"proof-building","strategicSignal":"Enterprise Business Ops, Service Delivery, Growth Engine, Capital Vitality, and pricing are coded, but proposal release should become mandatory-gated.","currentProof":["/enterprise-business-ops","/service-delivery","/growth-engine","/capital-vitality","/pricing"],"missingProof":["mandatory deal desk release checkbox","proposal-level margin snapshot","revenue-recognition triage note"],"leadingIndicator":"Every opportunity has package scope, price posture, acceptance criteria, billing trigger, and blocked claims before proposal release.","laggingIndicator":"Discounts, custom work, and strategic partnerships keep approved margin and external-review posture.","nextCheckpoint":"Add deal-desk review to every pilot, enterprise, investor-sponsored clinic, and strategic partner packet before proposal language expands.","escalationPath":"Revenue operations -> Finance -> Legal operations -> Founder when scope, margin, or contract authority is incomplete.","promotionCriteria":["price floor retained","scope and acceptance criteria defined","billing trigger documented","profit and reimbursement guarantees blocked"],"demotionTriggers":["unpriced custom work appears","discount lacks margin review","payment terms are unclear","proposal implies profit, revenue, or reimbursement guarantee"],"retainedBoundary":"Deal desk scorecard is not legal advice, accounting advice, tax advice, audited financial reporting, contract approval, revenue assurance, or profit assurance."},{"commandSlug":"buyer-proof-release-command","commandLane":"Buyer Proof Release","scoreState":"watch","evidenceState":"proof-building","strategicSignal":"Protected release controls exist, but external buyer proof should remain controlled until release authority, recipient, and reviewer records are complete.","currentProof":["/pilot-workspace/access","/qa-buyer-proof-release","/buyer-release-control-run","/trust-center"],"missingProof":["buyer-specific release authority reference","recipient-control attestation","buyer proof release approval packet"],"leadingIndicator":"Every buyer-specific proof request has release state, reviewer owner, recipient boundary, and export posture before sharing.","laggingIndicator":"Enterprise diligence packets move faster without public customer-proof, confidential artifact, or PHI leakage.","nextCheckpoint":"Require Buyer Release Control metadata before protected proof is referenced in sales, investor, or strategic partner materials.","escalationPath":"Release steward -> Legal operations -> Security -> Customer sponsor when proof is customer-specific or externally distributable.","promotionCriteria":["AAL2 workspace exists","release decision recorded","reviewer signoff linked","recipient control and claim guard complete"],"demotionTriggers":["public customer proof requested","unapproved export requested","signed approval storage requested","recipient list or confidential artifact would enter product storage"],"retainedBoundary":"Buyer proof scorecard is not customer permission, public release approval, legal approval, security certification, PHI authority, or clinical authority."},{"commandSlug":"interoperability-health-records-command","commandLane":"Interoperability and Health Records","scoreState":"active","evidenceState":"proof-ready","strategicSignal":"Standards maps, fixtures, health-record extraction planning, platform-power controls, and clinical production blockers are visible enough to sell readiness safely.","currentProof":["/interoperability","/integrations","/health-records","/platform-power","/clinical-production-readiness"],"missingProof":["buyer-facing connector trust catalog","technical-sales readiness packet","connector status label on pilot packets"],"leadingIndicator":"Connector discussions use synthetic-ready, contract-ready, protected-gated, or blocked-live-use status labels.","laggingIndicator":"Technical buyers purchase integration readiness before live connector, PHI, EHR writeback, or payer submission scope expands.","nextCheckpoint":"Promote connector trust labels into pilot and technical sales packets for FHIR, HL7, X12, DICOM, SMART, MCP, and extraction planning.","escalationPath":"Interoperability -> Health Records Safety -> Privacy/Security -> Clinical Governance when a live-data or production connector request appears.","promotionCriteria":["standards map exists","synthetic fixture exists","safety check exists","live-use blocker is visible"],"demotionTriggers":["certified EHR integration is implied","live patient sync requested","patient matching enters scope","payer submission or device command execution appears"],"retainedBoundary":"Interoperability scorecard is not production connector approval, PHI authority, EHR writeback approval, payer submission approval, device control, or clinical authority."},{"commandSlug":"enterprise-operating-layer-command","commandLane":"Enterprise Operating Layer","scoreState":"sequenced","evidenceState":"proof-building","strategicSignal":"Platform Power, Enterprise Scalability, Service Delivery, agents, TrustOS, and Product Console exist, but annual license packaging needs a readiness packet.","currentProof":["/platform-power","/enterprise-scalability","/service-delivery","/agents","/trust-os","/product"],"missingProof":["operating-layer license-readiness packet","support model assumptions","production tenancy and SLO language gate"],"leadingIndicator":"Enterprise buyers can inspect license scope, service work, platform controls, support boundary, and blocked claims before proposal.","laggingIndicator":"Assessment and pilot buyers convert into annual license, implementation work order, governance retainer, or scale-readiness review.","nextCheckpoint":"Create a license-readiness packet mapping Product Console proof counts to operating-layer scope, service work orders, and support boundaries.","escalationPath":"Platform -> Enterprise Scalability -> Service Delivery -> Finance/Legal when annual license or managed-service language appears.","promotionCriteria":["API/UI/AI controls visible","scale boundary visible","service work order visible","support and cost guardrails visible"],"demotionTriggers":["public API SLA implied","managed-service coverage implied","production model routing implied","PHI processing or scale-equivalence proof claimed"],"retainedBoundary":"Enterprise scorecard is not EHR replacement, public API SLA, managed-service commitment, production model-routing approval, PHI authority, or live autonomous AI."},{"commandSlug":"capital-partner-diligence-command","commandLane":"Capital and Partner Diligence","scoreState":"watch","evidenceState":"proof-building","strategicSignal":"Company Assessment, Investor Audience Readiness, Capital Vitality, Growth Engine, Public Market Readiness, and Competitive Intelligence exist, but packets need release discipline.","currentProof":["/company-assessment","/investor-audience-readiness","/capital-vitality","/growth-engine","/public-market-readiness","/competitive-intelligence"],"missingProof":["current investor packet version","claim-guarded moat evidence index","qualified finance/legal review note for sensitive materials"],"leadingIndicator":"Each capital or partner packet separates approved proof, readiness work, open gaps, blocked claims, and next investable milestone.","laggingIndicator":"Investor, clinic sponsor, corporate strategic, payer, health-system, and partner conversations convert into diligence next steps without securities drift.","nextCheckpoint":"Refresh investor and strategic packets after each deployed capability release with claim-guarded proof and no-securities boundaries.","escalationPath":"Founder -> Capital operations -> Finance -> Legal operations -> Claim Guard when investment, valuation, customer, or revenue language expands.","promotionCriteria":["current capability documented","moat evidence linked","revenue motion bounded","blocked claims and qualified-review needs visible"],"demotionTriggers":["securities offering implied","valuation assurance implied","audited financials implied","acquisition interest or customer revenue guarantee implied"],"retainedBoundary":"Capital scorecard is not investment advice, securities material, solicitation, valuation assurance, audited financial reporting, tax advice, or revenue guarantee."},{"commandSlug":"clinical-global-approval-command","commandLane":"Clinical and Global Approval Runway","scoreState":"sequenced","evidenceState":"external-review-required","strategicSignal":"Clinical Production Readiness, Clinical Authority, Approvals, Global Certification, Global Reach, and Continuous Review are structured, but production/global claims require qualified review.","currentProof":["/clinical-production-readiness","/clinical-authority-readiness","/approvals-readiness","/global-certification-readiness","/global-reach","/continuous-review-audit"],"missingProof":["qualified legal/regulatory review","external security/certification evidence","customer authority and clinical validation plan"],"leadingIndicator":"Every clinical or global opportunity has a region/use-case pack, approval blockers, reviewer owner, and safe current offer.","laggingIndicator":"SCRIMED monetizes readiness planning and no-PHI evaluation without claiming clinical or regional production approval early.","nextCheckpoint":"Prioritize which approval packets deserve qualified external counsel, auditor, security, or clinical-governance engagement first.","escalationPath":"Clinical Governance -> Privacy/Security -> Regional Counsel -> Founder when approval, certification, PHI, or live-care language appears.","promotionCriteria":["clinical production task status is current","approval track is defined","regional evidence class is defined","external reviewer owner is named"],"demotionTriggers":["FDA clearance implied","HIPAA assurance implied","EU AI Act or GDPR assurance implied","live clinical deployment implied"],"retainedBoundary":"Clinical/global scorecard is not legal advice, regulatory approval, HIPAA assurance, certification, regional approval, PHI authority, or live clinical care."}],"executionScorecardCurrentProofRoutes":["/product","/competitive-intelligence","/offerings","/pricing","/client-onboarding","/pilot-demo-commercial-readiness","/demos","/pilot-evidence","/health-records","/qa-evidence","/qa-buyer-proof-release","/enterprise-business-ops","/service-delivery","/growth-engine","/capital-vitality","/pilot-workspace/access","/buyer-release-control-run","/trust-center","/interoperability","/integrations","/platform-power","/clinical-production-readiness","/enterprise-scalability","/agents","/trust-os","/company-assessment","/investor-audience-readiness","/public-market-readiness","/clinical-authority-readiness","/approvals-readiness","/global-certification-readiness","/global-reach","/continuous-review-audit"],"executionScorecardMissingProof":["weekly CTA review artifact","buyer-path analytics export","deal-source conversion cohort","buyer-specific no-PHI proof ladder checklist","demo-to-pilot proof-packet template","approved proof-language registry for each demo","mandatory deal desk release checkbox","proposal-level margin snapshot","revenue-recognition triage note","buyer-specific release authority reference","recipient-control attestation","buyer proof release approval packet","buyer-facing connector trust catalog","technical-sales readiness packet","connector status label on pilot packets","operating-layer license-readiness packet","support model assumptions","production tenancy and SLO language gate","current investor packet version","claim-guarded moat evidence index","qualified finance/legal review note for sensitive materials","qualified legal/regulatory review","external security/certification evidence","customer authority and clinical validation plan"],"executionScorecardPromotionCriteria":["each target audience has one recommended offer path","price posture or band is visible","CTA routes to no-PHI intake or onboarding","blocked claims are visible before proposal language","synthetic fixture exists","source attribution exists","human-review checkpoint is named","live-data blocker is declared","price floor retained","scope and acceptance criteria defined","billing trigger documented","profit and reimbursement guarantees blocked","AAL2 workspace exists","release decision recorded","reviewer signoff linked","recipient control and claim guard complete","standards map exists","safety check exists","live-use blocker is visible","API/UI/AI controls visible","scale boundary visible","service work order visible","support and cost guardrails visible","current capability documented","moat evidence linked","revenue motion bounded","blocked claims and qualified-review needs visible","clinical production task status is current","approval track is defined","regional evidence class is defined","external reviewer owner is named"],"executionScorecardDemotionTriggers":["custom scope is requested before no-PHI intake","buyer cannot identify next step","CTA implies signed quote","ROI or customer-proof language appears without review","PHI upload requested","patient identifier intake appears","production credentials requested","EHR writeback or payer submission enters scope","unpriced custom work appears","discount lacks margin review","payment terms are unclear","proposal implies profit, revenue, or reimbursement guarantee","public customer proof requested","unapproved export requested","signed approval storage requested","recipient list or confidential artifact would enter product storage","certified EHR integration is implied","live patient sync requested","patient matching enters scope","payer submission or device command execution appears","public API SLA implied","managed-service coverage implied","production model routing implied","PHI processing or scale-equivalence proof claimed","securities offering implied","valuation assurance implied","audited financials implied","acquisition interest or customer revenue guarantee implied","FDA clearance implied","HIPAA assurance implied","EU AI Act or GDPR assurance implied","live clinical deployment implied"],"competitiveMarketIntelligence":{"service":"scrimed-competitive-market-intelligence","status":"competitor-informed-build-map-active","route":"/competitive-intelligence","apiRoute":"/api/competitive-intelligence","reviewedAt":"2026-07-08","boundary":"SCRIMED Competitive Market Intelligence translates public competitor positioning, product packaging, API posture, healthcare intelligence themes, sales motions, target-audience needs, and trust patterns into original SCRIMED build priorities. It does not copy third-party code, proprietary workflows, private APIs, branding, datasets, model weights, customer proof, security certifications, regulatory approvals, partnerships, or live clinical authority.","sourceCount":18,"sourceCategoryCount":10,"researchSignalCount":8,"researchSignalCategoryCount":6,"cleanRoomPlayCount":6,"cleanRoomImmediatePlayCount":3,"cleanRoomNearTermPlayCount":2,"cleanRoomStrategicPlayCount":1,"cleanRoomProductSystemCount":21,"cleanRoomPublicSourceCount":15,"cleanRoomProofMetricCount":6,"patternCount":5,"initiativeCount":5,"targetAudienceStrategyCount":10,"targetAudienceSegmentCount":10,"targetAudienceProofRouteCount":32,"targetAudienceBlockedClaimCount":40,"immediateTargetAudienceStrategyCount":6,"nearTermTargetAudienceStrategyCount":3,"protectedTargetAudienceStrategyCount":1,"implementedInitiativeCount":2,"packageNextInitiativeCount":3,"protectedGatedInitiativeCount":0,"externalReviewInitiativeCount":0,"productSurfaceCount":21,"agentCount":14,"infrastructureMoveCount":20,"proofMetricCount":25,"governanceGateCount":25,"blockedClaimCount":20,"sourceCategories":["ambient-clinical-intelligence","platform-incumbent","safety-agent-platform","agent-workforce","revenue-cycle","data-and-ai-platform","payer-operations","interoperability-network","imaging-ai","trust-and-security"],"researchSignalCategories":["ambient-clinical-intelligence","payer-operations","data-and-ai-platform","interoperability-network","imaging-ai","trust-and-security"],"productSurfaces":["/product","/demos","/evaluation","/workflows/results","/pilot-deal-room","/public-market-readiness","/pilot-workspace/access","/qa-evidence","/capital-vitality","/integrations","/interoperability","/workflows/contracts","/deployment-profiles","/trust-center","/agents/revenue-cycle-agent","/pricing","/atlas","/agents","/trust-os","/agent-workspace","/observability"],"agents":["Agent Commander","Clinical Intelligence Agent","Revenue Integrity Agent","TrustOS Reviewer","Metric Analyst Agent","Atlas Evidence Agent","QA Reviewer","Interoperability Agent","Contract Analyst","Security Reviewer","Deployment Planner","PayerIQ","Policy Evidence Agent","Appeals Reviewer"],"infrastructureMoves":["workflow loop schema","evidence trace packet","human-review checkpoint","downstream readiness register","buyer baseline capture","scorecard metric dictionary","specialty scenario tags","finance methodology gate","connector trust schema","API readiness labels","standards mapping","live-use blocker register","policy evidence map","denial root-cause taxonomy","appeal packet draft boundary","financial-impact guardrail","context layer declaration","agent activation policy","identity and audit map","deployment profile gate"],"proofMetrics":["workflow steps completed","evidence trace coverage","human-review turnaround","downstream blocker count","buyer decision readiness","baseline metric captured","scenario completion rate","reviewer confidence","documentation completeness","denial-risk signal quality","fixture coverage","contract completeness","blocked live-use controls","standards mapped","security prerequisites retained","policy references mapped","missing evidence surfaced","denial-risk reasons explained","appeal draft completeness","human override rate","context sources attributed","agent actions audited","trust decisions retained","deployment blockers resolved","protected workspace controls active"],"governanceGates":["synthetic-only input","no live writeback","human reviewer required","claim guard","protected release decision","buyer metric owner","external-use approval","finance methodology review","no unsupported ROI assurance","no certification claim","security review","BAA/DPA readiness","customer connector approval","data-minimization review","no live PHI until approved","no payer submission","no reimbursement guarantee","finance reviewer signoff","qualified coding review","human final action","role-based access","AAL2 operator proof","append-only audit","release control","external approval evidence"],"blockedClaims":["autonomous clinical action","production EHR integration","unsupported downstream savings assurance","customer-approved live deployment","best-in-market benchmark","unsupported ROI assurance","clinical superiority","certified specialty performance","certified EHR integration","live API availability","payer network connectivity","production PHI processing","unsupported reimbursement assurance","automated payer approval","final coding decision","payment integrity certification","unified live enterprise data","autonomous deployment","unapproved security attestation","regulatory approved"],"targetAudienceSegments":["Health system executives and transformation sponsors","CMIO, clinical operations, documentation, and quality leaders","Revenue-cycle, payer operations, prior authorization, denials, and appeals leaders","CIO, CTO, CISO, security, procurement, and implementation teams","Independent, community, rural, and faith-based clinics","Angel investors, private investors, corporate strategics, and board reviewers","Global partners, public-sector buyers, NGOs, and regional health systems","AI platform, innovation, research, and transformation leaders","Patient access, contact center, operations, and throughput leaders","Clinical governance, quality, safety, and risk committees"],"targetAudienceProofRoutes":["/company-assessment","/competitive-intelligence","/pilot-demo-commercial-readiness","/pilot-deal-room","/demos","/evaluation","/qa-evidence","/clinical-production-readiness","/agents/revenue-cycle-agent","/workflows/results","/pricing","/public-market-readiness","/interoperability","/trust-center","/platform-power","/enterprise-scalability","/pilot-workspace/access","/investor-audience-readiness","/offerings","/client-onboarding","/capital-vitality","/competitive-edge","/global-reach","/global-certification-readiness","/approvals-readiness","/continuous-review-audit","/agent-os","/trust-os","/strategic-intelligence","/service-delivery","/operational-efficiency","/qa-claim-guard"],"targetAudienceBlockedClaims":["EHR replacement","unsupported system-wide savings assurance","customer-approved live deployment","clinical production ready","autonomous note signing","diagnosis or treatment authority","certified specialty performance","live PHI processing","unsupported reimbursement assurance","automated payer approval","final coding decision","claim submission authority","certified EHR integration","unapproved security attestation","public API SLA","production PHI processing","faith-based endorsement","donor or nonprofit tax advice","unsupported affordability assurance","live care authorization","securities offering","valuation assurance","revenue guarantee","acquisition interest","regional compliance approval","public-sector procurement approval","GDPR assurance","NHS or MHRA approval","production model-routing approval","public quantum capability","autonomous clinical agents","model-safety certification","autonomous patient outreach","unsupported staffing reduction assurance","managed 24/7 operations","contractual SLA","clinical validation complete","diagnostic authority","IRB approval","autonomous care"],"cleanRoomProductSystems":["/pilot-deal-room","/qa-evidence","/public-market-readiness","/investor-audience-readiness","/trust-center","/scrimed-cyber-defense","/api/scrimed-cyber-defense/evidence-packet","/interoperability","/integrations","/health-records","/deployment-profiles","/workflows/results","/agents/revenue-cycle-agent","/pricing","/capital-vitality","/scrimed-ai-infrastructure-watchtower","/clinical-data-fabric","/trust-os","/offerings","/client-onboarding","/sales-operations"],"cleanRoomPublicSources":["Abridge","Ambience Healthcare","Cohere Health","Aidoc","Notable Trust Center","Redox","Health Gorilla","Nabla","Innovaccer","SmarterDx","Commure","Notable","Rad AI","PathAI","Freed"],"cleanRoomProofMetrics":["buyer-proof-packet-completeness","security-diligence-evidence-ready-count","connector-readiness-label-coverage","payer-evidence-gap-resolution-rate","imaging-handoff-audit-coverage","offer-to-proof-route-completeness"],"cleanRoomRetainedBoundaries":["No live PHI, no customer proof claims, no unsupported ROI assurance, no clinical validation claim, and no production go-live authority.","No certification claim, no breach-proof claim, no PHI authority, no raw security artifact sharing, and no customer go-live approval.","No live exchange, no production connector approval, no network participation claim, no EHR writeback, and no PHI processing.","No payer submission, no claim filing, no automated approval, no reimbursement guarantee, and no final coding authority.","No final imaging interpretation, no FDA claim, no diagnosis, no live DICOM, and no treatment recommendation.","No securities solicitation, no revenue guarantee, no customer activation promise, no PHI use, and no clinical production claim."],"sources":[{"name":"Abridge","category":"ambient-clinical-intelligence","url":"https://www.abridge.com/","observedPattern":"Abridge packages ambient clinical intelligence as a full care workflow across pre-visit context, encounter documentation, post-visit actions, clinician documentation, revenue-cycle specificity, nursing workflows, customer outcomes, and research-backed evaluation.","scrimedTranslation":"SCRIMED should make every workflow demo feel like a full operating loop: intake or context, agent execution, evidence trace, human review, buyer outcome, and downstream readiness packet.","noCopyBoundary":"Do not copy clinical documentation models, customer claims, private datasets, specialty rubrics, branding, or partnership language."},{"name":"Ambience Healthcare","category":"ambient-clinical-intelligence","url":"https://www.ambiencehealthcare.com/","observedPattern":"Ambience emphasizes documentation plus coding, competitive bake-off proof, specialty adoption, utilization, NPS, charting-time reduction, and compliance-oriented clinical standards.","scrimedTranslation":"SCRIMED should turn pilots into scored specialty bake-offs with buyer-defined baseline metrics, time-to-value evidence, review utilization, and no-PHI proof packets.","noCopyBoundary":"Do not reuse Ambience comparative claims, customer quotes, or specialty implementation details; build SCRIMED-specific synthetic measurements."},{"name":"Nabla","category":"ambient-clinical-intelligence","url":"https://www.nabla.com/","observedPattern":"Nabla surfaces web, mobile, extension, EHR integration, developer API, security, privacy, and governance posture as part of the product buying motion.","scrimedTranslation":"SCRIMED should present API, connector, identity, mobile-adjacent, and security-readiness signals as first-class product primitives before live integration.","noCopyBoundary":"Do not claim Nabla-compatible integrations, certifications, or product parity; use public API posture as a market expectation only."},{"name":"Suki","category":"ambient-clinical-intelligence","url":"https://www.suki.ai/","observedPattern":"Suki positions ambient clinical intelligence as AI infrastructure across documentation, assisted revenue cycle, clinical reasoning, major EHR integrations, partner tooling, enterprise security, and measurable clinical and financial ROI.","scrimedTranslation":"SCRIMED should answer with governed workflow intelligence that pairs documentation-adjacent demos with revenue, reasoning, interoperability, and security gates rather than a narrow note-taking story.","noCopyBoundary":"Do not copy Suki integration claims, ROI claims, trust-portal claims, EHR embedding language, UI, partner toolkit, or customer proof."},{"name":"Microsoft Dragon Copilot","category":"platform-incumbent","url":"https://www.microsoft.com/en-us/ai/health","observedPattern":"Microsoft positions healthcare AI around trusted AI, Dragon Copilot clinical workflow assistance, health-data protection, Azure-scale platform services, Microsoft Fabric, Defender, Teams, Power Platform, and enterprise customer stories.","scrimedTranslation":"SCRIMED should not try to sound larger than Microsoft; it should win with a sharper healthcare operating layer, faster no-PHI buyer proof, evidence-first agent governance, and clean integration boundaries.","noCopyBoundary":"Do not imply Microsoft partnership, Azure equivalence, Dragon Copilot parity, Fabric replacement, Defender-managed security, or enterprise-scale certification."},{"name":"Oracle Health","category":"platform-incumbent","url":"https://www.oracle.com/health/","observedPattern":"Oracle Health positions healthcare AI as an enterprise-grade cloud, EHR, interoperability, payer, financial, population health, security, services, and data-platform ecosystem.","scrimedTranslation":"SCRIMED should frame itself as an overlay intelligence and proof layer that complements incumbent systems while preparing connector, payer, financial, and security evidence before production use.","noCopyBoundary":"Do not imply Oracle certification, EHR replacement, ONC-certified status, Oracle Health integration, clinical-suite parity, or enterprise security certification."},{"name":"Hippocratic AI","category":"safety-agent-platform","url":"https://www.hippocraticai.com/","observedPattern":"Hippocratic AI foregrounds safety-first healthcare agents, human escalation, broad agent libraries, non-diagnosis/non-prescribing boundaries, clinical validation claims, customer logos, and capital strength.","scrimedTranslation":"SCRIMED should turn TrustOS, human review, escalation, and no-live-care boundaries into a product strength while avoiding public claims that require clinical validation, licensure, or customer approval.","noCopyBoundary":"Do not copy agent catalogs, safety benchmarks, clinical validation claims, customer logos, call examples, funding claims, or voice-agent experience."},{"name":"Notable","category":"agent-workforce","url":"https://www.notablehealth.com/","observedPattern":"Notable sells an AI agent workforce across patient access, revenue cycle, care operations, contact center, low-code flow building, connector hub integration, and measurable operational outcomes.","scrimedTranslation":"SCRIMED should package AgentOS as a governed workforce builder with reusable workflow templates, connector contracts, operator approval gates, and buyer-owned success metrics.","noCopyBoundary":"Do not copy Notable Flow Builder, connector implementation, UI, customer results, or automation claims; build original templates and proofs."},{"name":"Commure","category":"revenue-cycle","url":"https://www.commure.com/","observedPattern":"Commure packages front-end patient access, mid-cycle clinical intelligence, and back-end revenue integrity around one data model, EHR breadth, ambient AI, RCM automation, and quantified scale.","scrimedTranslation":"SCRIMED should make the patient-access-to-ledger story inspectable through synthetic workflows that connect access friction, documentation evidence, payer friction, and financial-risk review.","noCopyBoundary":"Do not copy Commure scale claims, EHR counts, customer logos, billing automation, or end-to-end RCM implementation claims."},{"name":"Innovaccer","category":"data-and-ai-platform","url":"https://innovaccer.com/","observedPattern":"Innovaccer positions an agentic cloud built on unified data, real-time context, governed activation, enterprise identity resolution, and launchable AI agents.","scrimedTranslation":"SCRIMED should strengthen Atlas as a governed context layer and AgentOS as the activation layer for synthetic-to-protected enterprise pilots.","noCopyBoundary":"Do not imply unified enterprise data ingestion, identity resolution, or production cloud deployment until customer-approved connectors exist."},{"name":"SmarterDx","category":"revenue-cycle","url":"https://www.smarterdx.com/","observedPattern":"SmarterDx focuses on clinical evidence hidden in patient records, 100% chart coverage, diagnosis and charge validation, denials, utilization, ROI proof, and secure revenue-cycle trust.","scrimedTranslation":"SCRIMED should turn PayerIQ and Atlas into evidence-first revenue-risk demos with chart-story completeness, denial-root-cause explanation, and finance-methodology gates.","noCopyBoundary":"Do not reuse SmarterDx ROI claims, security claims, chart algorithms, or customer proof; keep SCRIMED metrics buyer-reviewed and synthetic."},{"name":"Cohere Health","category":"payer-operations","url":"https://www.coherehealth.com/","observedPattern":"Cohere Health connects utilization management, prior authorization, payment integrity, appeals, care management, quality, claims operations, APIs, and policy tooling with humans in control.","scrimedTranslation":"SCRIMED should make payer and plan workflows policy-aware, API-shaped, appeal-ready, specialty-scoped, and explicitly human-controlled before production authority.","noCopyBoundary":"Do not copy Cohere portals, policy rules, payer criteria, network claims, or real-time authorization claims."},{"name":"Freed","category":"ambient-clinical-intelligence","url":"https://www.getfreed.ai/","observedPattern":"Freed sells simple AI medical scribe value to individual clinicians and smaller practices through a low-friction product promise, quick documentation relief, and self-serve buying motion.","scrimedTranslation":"SCRIMED should keep a lower-friction clinic path that sells no-PHI readiness, workflow relief, and mission-aligned governance without forcing every prospect into a large enterprise package.","noCopyBoundary":"Do not copy Freed pricing, self-serve funnel claims, documentation output, UI, customer claims, or small-practice adoption language."},{"name":"Qventus","category":"agent-workforce","url":"https://www.qventus.com/","observedPattern":"Qventus positions healthcare operations automation around capacity, perioperative flow, inpatient operations, discharge, and measurable operational improvements for hospitals.","scrimedTranslation":"SCRIMED should make patient access, operations, throughput, and staffing-friction workflows visible as governed synthetic operating loops with human review and no managed-service guarantee.","noCopyBoundary":"Do not copy Qventus operational models, hospital customer claims, implementation playbooks, ROI claims, or capacity-management algorithms."},{"name":"Redox","category":"interoperability-network","url":"https://redoxengine.com/","observedPattern":"Redox positions interoperability as real-time healthcare data exchange, cloud data activation, network reach, managed services, API documentation, security posture, and marketplace availability.","scrimedTranslation":"SCRIMED should make its integration posture more inspectable through connector trust labels, fixture status, standards mapping, security prerequisites, and buyer-ready API boundaries.","noCopyBoundary":"Do not copy Redox APIs, network claims, uptime claims, certification claims, customer quotes, partner marketplace claims, or live integration claims."},{"name":"Health Gorilla","category":"interoperability-network","url":"https://healthgorilla.com/","observedPattern":"Health Gorilla makes national data exchange, TEFCA/QHIN-style positioning, productized clinical data categories, payer/provider markets, API docs, and security posture visible in the sales motion.","scrimedTranslation":"SCRIMED should track TEFCA, HIE, EHR, lab, ADT, pharmacy, SDOH, and patient-access data readiness as approval-path metadata until live exchange is authorized.","noCopyBoundary":"Do not imply QHIN/QHIO status, TEFCA participation, government designation, national network participation, lab network connectivity, or patient data access."},{"name":"Aidoc","category":"imaging-ai","url":"https://www.aidoc.com/","observedPattern":"Aidoc packages imaging AI as a clinical workflow and care-team activation platform across radiology, cardiology, neurovascular, vascular, notifications, follow-up, governance, and strategy resources.","scrimedTranslation":"SCRIMED should frame imaging intelligence as imaging-to-action workflow readiness: metadata ingestion, triage workflow simulation, care-team handoff, audit, and human radiology authority boundaries.","noCopyBoundary":"Do not copy Aidoc algorithms, FDA-cleared indications, customer outcomes, care-team workflow implementation, clinical claims, or imaging interpretation authority."},{"name":"Notable Trust Center","category":"trust-and-security","url":"https://trust.notablehealth.com/","observedPattern":"Notable exposes a trust center with security review workflow, compliance badges, risk profile, reports, product security, data privacy, access control, infrastructure, endpoint security, policies, and vulnerability reporting.","scrimedTranslation":"SCRIMED should keep building its Trust Center, Cyber Defense Command Center, security evidence packet, no-secret contracts, and external-evidence gaps as buyer-visible trust assets.","noCopyBoundary":"Do not copy third-party trust center content, badges, reports, customer logos, policy documents, certification claims, or downloadable security artifacts."}],"researchSignals":[{"sourceName":"Abridge","sourceUrl":"https://www.abridge.com/","category":"ambient-clinical-intelligence","currentPublicSignal":"Ambient AI leaders are selling an end-to-end clinical conversation platform: pre-visit context, live encounter support, post-visit documentation, coding specificity, patient summaries, outcomes reporting, and research-backed evaluation.","scrimedImplication":"SCRIMED should sell governed care-workflow intelligence, not isolated note generation: context, execution, evidence, human review, downstream readiness, and blocked-authority clarity.","implementationStatus":"implemented","lastReviewed":"2026-07-08"},{"sourceName":"Ambience Healthcare","sourceUrl":"https://www.ambiencehealthcare.com/","category":"ambient-clinical-intelligence","currentPublicSignal":"Ambient vendors are using utilization, charting-time reduction, NPS, specialty fit, coding, compliance, and competitive bake-off narratives as enterprise buyer proof.","scrimedImplication":"SCRIMED should turn demos into buyer-defined scorecards and synthetic specialty bake-offs with reviewer confidence, evidence quality, workflow value, and claim safety metrics.","implementationStatus":"package-next","lastReviewed":"2026-07-08"},{"sourceName":"Cohere Health","sourceUrl":"https://www.coherehealth.com/","category":"payer-operations","currentPublicSignal":"Payer-operation platforms are connecting utilization management, payment integrity, appeals, care management, quality, claims operations, policy intelligence, and human-in-control workflows.","scrimedImplication":"SCRIMED should upgrade PayerIQ around documentation-before-authorization, denial-risk explanations, appeal packet readiness, payment-integrity review, and explicit no-submission gates.","implementationStatus":"package-next","lastReviewed":"2026-07-08"},{"sourceName":"Innovaccer","sourceUrl":"https://innovaccer.com/","category":"data-and-ai-platform","currentPublicSignal":"Healthcare AI platforms are converging around unified data foundations, real-time context, voice and workflow agents, activation in weeks, and cross-domain healthcare operations.","scrimedImplication":"SCRIMED should make Atlas, AgentOS, TrustOS, and protected workspaces feel like one governed context-to-agent-to-proof operating system.","implementationStatus":"implemented","lastReviewed":"2026-07-08"},{"sourceName":"Redox","sourceUrl":"https://redoxengine.com/","category":"interoperability-network","currentPublicSignal":"Integration vendors are selling real-time healthcare data movement, cloud activation, API documentation, network breadth, security posture, and managed integration services.","scrimedImplication":"SCRIMED should strengthen its connector trust catalog and be explicit about synthetic-ready, contract-ready, protected-gated, and live-use-blocked integration states.","implementationStatus":"package-next","lastReviewed":"2026-07-08"},{"sourceName":"Health Gorilla","sourceUrl":"https://healthgorilla.com/","category":"interoperability-network","currentPublicSignal":"Health data network buyers expect TEFCA, HIE, payer, provider, lab, pharmacy, ADT, SDOH, API, and security readiness to be easy to inspect.","scrimedImplication":"SCRIMED should track national exchange and data-category readiness as an approvals roadmap while clearly blocking live exchange and network claims.","implementationStatus":"monitor","lastReviewed":"2026-07-08"},{"sourceName":"Aidoc","sourceUrl":"https://www.aidoc.com/","category":"imaging-ai","currentPublicSignal":"Imaging AI leaders are moving beyond algorithm lists into care-team activation, follow-up, workflow prioritization, governance, and outcome-oriented clinical operations.","scrimedImplication":"SCRIMED should build imaging-to-action simulations: imaging metadata, routing, handoff, follow-up, governance, and no-final-interpretation safeguards.","implementationStatus":"package-next","lastReviewed":"2026-07-08"},{"sourceName":"Notable Trust Center","sourceUrl":"https://trust.notablehealth.com/","category":"trust-and-security","currentPublicSignal":"Enterprise buyers expect a structured trust center, report request workflow, risk profile, access control, product security, data privacy, infrastructure, endpoint security, policies, and vulnerability reporting.","scrimedImplication":"SCRIMED should continue turning trust into a product surface through Cyber Defense, Security Diligence Evidence Packet, Trust Center, no-secret checks, and blocked external evidence lanes.","implementationStatus":"implemented","lastReviewed":"2026-07-08"}],"cleanRoomPlays":[{"slug":"proof-before-pilot-command","priority":"immediate","marketPattern":"Leading competitors convert vague AI value into buyer-visible proof: utilization, time saved, workflow coverage, adoption, policy friction, and operational outcomes.","publicSources":["Abridge","Ambience Healthcare","Cohere Health","Aidoc"],"legalExtractionRule":"Use only the general public pattern of proof-first selling; create SCRIMED-original metrics, copy, workflows, and evidence packets.","prohibitedCopying":["competitor charts","customer quotes","customer logos","private benchmark rubrics","ROI claims","clinical validation claims"],"scrimedOriginalImplementation":"Package SCRIMED demos as proof-before-pilot scorecards with baseline, synthetic scenario, workflow loop, evidence coverage, human review, and blocked authority.","productSystemsToUpgrade":["/pilot-deal-room","/qa-evidence","/public-market-readiness","/investor-audience-readiness"],"revenueMotion":"Sell a fixed-scope no-PHI proof sprint before larger protected pilots, then convert qualified buyers into department-specific packages.","salesPitchUpgrade":"Before you expose data or commit to production, SCRIMED shows exactly what can be proven, reviewed, and blocked.","investorConfidenceSignal":"Demonstrates disciplined enterprise sales motion and reduces perceived execution risk.","privacyAndTrustControl":"No-PHI scenarios only, redacted artifacts, claim guard, human review, and no production authority language.","proofMetric":"buyer-proof-packet-completeness","nextBuildAction":"Add a proof-before-pilot packet to Pilot Deal Room that pulls from QA Evidence, Competitive Intelligence, and Security Diligence Evidence.","retainedBoundary":"No live PHI, no customer proof claims, no unsupported ROI assurance, no clinical validation claim, and no production go-live authority."},{"slug":"trust-center-as-sales-asset","priority":"immediate","marketPattern":"Enterprise healthcare vendors increasingly make trust centers, security reports, risk profiles, privacy posture, access control, and vulnerability reporting part of the buying journey.","publicSources":["Notable Trust Center","Redox","Ambience Healthcare"],"legalExtractionRule":"Use the general enterprise-buying expectation for a trust surface; publish only SCRIMED-owned statuses, gaps, evidence, and no-go boundaries.","prohibitedCopying":["third-party trust center layout","badges","security report names","certification claims","policy text","customer review artifacts"],"scrimedOriginalImplementation":"Expand SCRIMED Trust Center with security evidence packet, release readiness ladder, external evidence checklist, and buyer-safe redaction rules.","productSystemsToUpgrade":["/trust-center","/scrimed-cyber-defense","/api/scrimed-cyber-defense/evidence-packet"],"revenueMotion":"Shorten security-review friction by giving buyers a redacted diligence path before procurement stalls.","salesPitchUpgrade":"SCRIMED does not hide its limits; it packages trust evidence and blocked authority so buyers can review safely.","investorConfidenceSignal":"Signals enterprise procurement maturity without overstating certification or production status.","privacyAndTrustControl":"Metadata-only evidence, no raw logs, no tokens, no secrets, no connector payloads, and external review gates.","proofMetric":"security-diligence-evidence-ready-count","nextBuildAction":"Link Security Diligence Evidence Packet into Trust Center and buyer deal-room packet manifests.","retainedBoundary":"No certification claim, no breach-proof claim, no PHI authority, no raw security artifact sharing, and no customer go-live approval."},{"slug":"connector-trust-catalog","priority":"near-term","marketPattern":"Interoperability leaders make APIs, network scope, standards coverage, cloud activation, security posture, and data categories visible early.","publicSources":["Redox","Health Gorilla","Nabla","Innovaccer"],"legalExtractionRule":"Use the public buyer expectation for inspectable integration readiness; do not claim connectivity, network participation, designation, or implementation parity.","prohibitedCopying":["API schemas","network claims","standardized integration code","EHR connection lists","QHIN/QHIO designation language","uptime claims"],"scrimedOriginalImplementation":"Create SCRIMED connector trust labels for FHIR, HL7, DICOM, X12, SMART, MCP, HIE, lab, pharmacy, ADT, SDOH, and payer data categories.","productSystemsToUpgrade":["/interoperability","/integrations","/health-records","/deployment-profiles"],"revenueMotion":"Offer integration readiness reviews as paid pre-implementation work that reduces buyer uncertainty and scopes services cleanly.","salesPitchUpgrade":"SCRIMED shows which integrations are synthetic-ready, contract-ready, protected-gated, or blocked before anyone touches live systems.","investorConfidenceSignal":"Turns interoperability from a vague promise into a visible implementation moat and service revenue path.","privacyAndTrustControl":"No raw connector payloads, no live data exchange, data-minimization review, customer approval gate, and security evidence prerequisite.","proofMetric":"connector-readiness-label-coverage","nextBuildAction":"Add connector trust catalog data to interoperability fixture cards and deployment profile pages.","retainedBoundary":"No live exchange, no production connector approval, no network participation claim, no EHR writeback, and no PHI processing."},{"slug":"payer-policy-evidence-loop","priority":"immediate","marketPattern":"Payer and RCM competitors connect prior authorization, documentation precision, payment integrity, appeals, quality, claims operations, and human-in-control decisioning.","publicSources":["Cohere Health","SmarterDx","Commure","Notable"],"legalExtractionRule":"Use the public workflow pattern of connected payer evidence; create SCRIMED-original synthetic rules, packets, review gates, and human boundaries.","prohibitedCopying":["payer criteria libraries","portal behavior","payment-integrity algorithms","claims workflows","customer ROI proof","submission logic"],"scrimedOriginalImplementation":"Upgrade PayerIQ into a documentation-before-authorization and denial-risk evidence loop with missing evidence, medical-necessity phrasing gaps, appeal packet readiness, and human signoff.","productSystemsToUpgrade":["/workflows/results","/agents/revenue-cycle-agent","/pricing","/capital-vitality"],"revenueMotion":"Sell payer-friction assessments and protected revenue-cycle pilots priced around workflow volume and review complexity.","salesPitchUpgrade":"SCRIMED helps find missing evidence and payer friction before submission, while final action stays with qualified humans.","investorConfidenceSignal":"Creates a concrete revenue wedge with clear margin potential and safety gates.","privacyAndTrustControl":"Synthetic scenarios, no payer submission, no reimbursement guarantee, finance methodology review, and qualified human approval.","proofMetric":"payer-evidence-gap-resolution-rate","nextBuildAction":"Add one synthetic payer-policy evidence loop to the competitive demo queue and public-market readiness proof map.","retainedBoundary":"No payer submission, no claim filing, no automated approval, no reimbursement guarantee, and no final coding authority."},{"slug":"imaging-to-action-without-interpretation","priority":"near-term","marketPattern":"Imaging AI leaders package value around workflow prioritization, care-team activation, follow-up, governance, and measurable operational impact.","publicSources":["Aidoc","Rad AI","PathAI"],"legalExtractionRule":"Use the general workflow idea of moving from imaging metadata to governed follow-up actions; do not copy algorithms, clinical indications, or regulated claims.","prohibitedCopying":["imaging models","regulated indications","triage algorithms","clinical outcome claims","customer workflows","final interpretation language"],"scrimedOriginalImplementation":"Build an imaging-to-action readiness scaffold: DICOM metadata intake, synthetic finding label, routing simulation, care-team handoff, follow-up queue, audit, and radiologist authority boundary.","productSystemsToUpgrade":["/scrimed-ai-infrastructure-watchtower","/clinical-data-fabric","/trust-os"],"revenueMotion":"Package imaging workflow readiness as a governance and operations assessment for radiology, cardiology, oncology, and specialty service lines.","salesPitchUpgrade":"SCRIMED can help govern the work around imaging AI before claiming interpretation authority.","investorConfidenceSignal":"Keeps SCRIMED in high-value imaging workflows while avoiding premature regulated-device claims.","privacyAndTrustControl":"Metadata-only demos, no diagnostic interpretation, human specialist review, no live DICOM, and no regulated-device claim.","proofMetric":"imaging-handoff-audit-coverage","nextBuildAction":"Add imaging-to-action synthetic workflow metadata to the Clinical Data Fabric and AI Infrastructure Watchtower.","retainedBoundary":"No final imaging interpretation, no FDA claim, no diagnosis, no live DICOM, and no treatment recommendation."},{"slug":"audience-specific-revenue-packaging","priority":"strategic","marketPattern":"Competitors sell by audience: enterprise health systems, payer operations, independent clinicians, public sector, implementation partners, investors, and specialty workflows.","publicSources":["Abridge","Ambience Healthcare","Freed","Innovaccer","Cohere Health"],"legalExtractionRule":"Use only the general segmentation strategy; create SCRIMED-original offers, names, prices, success criteria, and disclaimers.","prohibitedCopying":["pricing tables","package names","conversion funnels","customer proof","logo walls","trademarked program language"],"scrimedOriginalImplementation":"Strengthen SCRIMED’s offer ladder: clinic starter, executive assessment, specialty bake-off, payer evidence review, connector trust review, protected pilot, and enterprise diligence room.","productSystemsToUpgrade":["/pricing","/offerings","/client-onboarding","/sales-operations","/investor-audience-readiness"],"revenueMotion":"Create margin-protected paid assessments that ladder into pilots and enterprise subscriptions without requiring live PHI first.","salesPitchUpgrade":"SCRIMED meets each buyer at the right risk level: starter proof, governed pilot, or enterprise diligence.","investorConfidenceSignal":"Shows diversified revenue paths and a practical path from no-PHI proof to enterprise expansion.","privacyAndTrustControl":"Each offer has a data boundary, approval gate, proof artifact, blocked claim list, and required reviewer role.","proofMetric":"offer-to-proof-route-completeness","nextBuildAction":"Add clean-room competitor-response offers to pricing and sales-operations packets.","retainedBoundary":"No securities solicitation, no revenue guarantee, no customer activation promise, no PHI use, and no clinical production claim."}],"patterns":[{"slug":"full-workflow-operating-loop","title":"Full Workflow Operating Loop","priority":"now","sourceNames":["Abridge","Commure","Notable"],"marketSignal":"Winning healthcare AI platforms show the complete path from context to action to downstream operational result, not a single chat or document feature.","productTranslation":"Every SCRIMED demo and pilot should show context intake, agent execution, evidence trace, human review, operational output, and retained buyer decision evidence.","buildImplementation":"Expose a competitor-informed workflow loop that links Product Console, Demo Center, AgentOS evaluation, workflow results, pilot deal room, and protected workspace evidence.","productSurfaces":["/product","/demos","/evaluation","/workflows/results","/pilot-deal-room"],"agents":["Agent Commander","Clinical Intelligence Agent","Revenue Integrity Agent","TrustOS Reviewer"],"infrastructureMoves":["workflow loop schema","evidence trace packet","human-review checkpoint","downstream readiness register"],"healthcareIntelligenceUpgrade":"Move from feature list to operating-loop proof that shows how healthcare work becomes governed intelligence.","salesPitchUpgrade":"SCRIMED is not an isolated scribe or chatbot; it is a review-gated operating loop for healthcare workflows.","proofMetrics":["workflow steps completed","evidence trace coverage","human-review turnaround","downstream blocker count","buyer decision readiness"],"governanceGates":["synthetic-only input","no live writeback","human reviewer required","claim guard","protected release decision"],"blockedClaims":["autonomous clinical action","production EHR integration","unsupported downstream savings assurance","customer-approved live deployment"],"nextImplementation":"Add a visible operating-loop summary to Demo Center and Pilot Deal Room cards."},{"slug":"specialty-bakeoff-scorecards","title":"Specialty Bake-Off Scorecards","priority":"now","sourceNames":["Ambience Healthcare","Abridge","SmarterDx"],"marketSignal":"Healthcare buyers expect specialty-level proof, adoption metrics, time saved, evidence quality, and comparative readiness before scaling an AI platform.","productTranslation":"SCRIMED should provide buyer-defined synthetic bake-off scorecards for access, documentation, revenue cycle, payer, research, and governance workflows.","buildImplementation":"Use existing protected metric rollups, board scorecards, QA evidence, and public-market readiness metrics as the foundation for scorecard-style sales proof.","productSurfaces":["/public-market-readiness","/pilot-workspace/access","/qa-evidence","/capital-vitality"],"agents":["Metric Analyst Agent","Atlas Evidence Agent","QA Reviewer","Revenue Integrity Agent"],"infrastructureMoves":["buyer baseline capture","scorecard metric dictionary","specialty scenario tags","finance methodology gate"],"healthcareIntelligenceUpgrade":"Convert broad AI claims into specialty-scoped, reviewer-owned measurements that can survive buyer diligence.","salesPitchUpgrade":"Run SCRIMED against your workflow criteria before exposing data or asking your teams to trust a production claim.","proofMetrics":["baseline metric captured","scenario completion rate","reviewer confidence","documentation completeness","denial-risk signal quality"],"governanceGates":["buyer metric owner","external-use approval","finance methodology review","no unsupported ROI assurance","no certification claim"],"blockedClaims":["best-in-market benchmark","unsupported ROI assurance","clinical superiority","certified specialty performance"],"nextImplementation":"Create a competitive bake-off packet template for no-PHI workflow pilots."},{"slug":"api-and-connector-trust-catalog","title":"API and Connector Trust Catalog","priority":"next","sourceNames":["Nabla","Cohere Health","Notable","Innovaccer"],"marketSignal":"Competitors make APIs, EHR connectivity, connector hubs, policy tooling, and trust posture visible early in the sales cycle.","productTranslation":"SCRIMED should display connector intent, API shape, standards coverage, live-use blockers, security prerequisites, and synthetic fixture readiness in one buyer catalog.","buildImplementation":"Extend existing integration fixtures, interoperability conformance, contracts, deployment profiles, and protected provider security review into a buyer-facing connector trust catalog.","productSurfaces":["/integrations","/interoperability","/workflows/contracts","/deployment-profiles","/trust-center"],"agents":["Interoperability Agent","Contract Analyst","Security Reviewer","Deployment Planner"],"infrastructureMoves":["connector trust schema","API readiness labels","standards mapping","live-use blocker register"],"healthcareIntelligenceUpgrade":"Make interoperability feel like a governed product asset rather than a future implementation promise.","salesPitchUpgrade":"Buyers can inspect exactly which connectors are synthetic-ready, contract-ready, or blocked before production.","proofMetrics":["fixture coverage","contract completeness","blocked live-use controls","standards mapped","security prerequisites retained"],"governanceGates":["security review","BAA/DPA readiness","customer connector approval","data-minimization review","no live PHI until approved"],"blockedClaims":["certified EHR integration","live API availability","payer network connectivity","production PHI processing"],"nextImplementation":"Add connector trust labels to interoperability and integration fixture cards."},{"slug":"revenue-and-payer-evidence-engine","title":"Revenue and Payer Evidence Engine","priority":"now","sourceNames":["SmarterDx","Cohere Health","Commure","Notable"],"marketSignal":"Revenue-cycle and payer competitors win by making policy evidence, documentation specificity, denials, appeals, utilization, and payment integrity operationally measurable.","productTranslation":"SCRIMED should sharpen PayerIQ into a synthetic evidence engine for prior authorization support, denial root-cause analysis, appeal packet preparation, and revenue-risk review.","buildImplementation":"Route PayerIQ through Atlas evidence attribution, workflow result validation, finance methodology gates, and human reviewer controls.","productSurfaces":["/agents/revenue-cycle-agent","/workflows/results","/pricing","/public-market-readiness","/pilot-workspace/access"],"agents":["PayerIQ","Revenue Integrity Agent","Policy Evidence Agent","Appeals Reviewer"],"infrastructureMoves":["policy evidence map","denial root-cause taxonomy","appeal packet draft boundary","financial-impact guardrail"],"healthcareIntelligenceUpgrade":"Turn payer and RCM workflows into evidence-backed operating intelligence without submitting claims or promising reimbursement.","salesPitchUpgrade":"SCRIMED helps teams find missing evidence and payer friction before value leaks, while keeping final payer actions with humans.","proofMetrics":["policy references mapped","missing evidence surfaced","denial-risk reasons explained","appeal draft completeness","human override rate"],"governanceGates":["no payer submission","no reimbursement guarantee","finance reviewer signoff","qualified coding review","human final action"],"blockedClaims":["unsupported reimbursement assurance","automated payer approval","final coding decision","payment integrity certification"],"nextImplementation":"Package one no-PHI denial-risk and prior-auth evidence demo for enterprise revenue-cycle buyers."},{"slug":"governed-context-and-agent-activation","title":"Governed Context and Agent Activation","priority":"platform","sourceNames":["Innovaccer","Nabla","Abridge","Cohere Health"],"marketSignal":"Enterprise AI platforms are converging on unified context, governed activation, reusable agents, identity, auditability, and human-in-control assurances.","productTranslation":"SCRIMED should position Atlas as the context and evidence layer, AgentOS as the activation layer, TrustOS as the decision-control layer, and protected workspaces as the enterprise operating boundary.","buildImplementation":"Make the route map explicit across Atlas, AgentOS, TrustOS, deployment profiles, protected workspaces, audit, observability, and release governance.","productSurfaces":["/atlas","/agents","/trust-os","/deployment-profiles","/agent-workspace","/observability"],"agents":["Atlas Evidence Agent","Agent Commander","TrustOS Reviewer","Deployment Planner"],"infrastructureMoves":["context layer declaration","agent activation policy","identity and audit map","deployment profile gate"],"healthcareIntelligenceUpgrade":"Define the healthcare intelligence OS as layered infrastructure with governed context, activation, trust, and deployment controls.","salesPitchUpgrade":"SCRIMED gives buyers a healthcare AI operating layer they can inspect before it touches live systems.","proofMetrics":["context sources attributed","agent actions audited","trust decisions retained","deployment blockers resolved","protected workspace controls active"],"governanceGates":["role-based access","AAL2 operator proof","append-only audit","release control","external approval evidence"],"blockedClaims":["unified live enterprise data","autonomous deployment","unapproved security attestation","regulatory approved"],"nextImplementation":"Add the layered architecture pitch to Strategic Intelligence and Competitive Edge."}],"initiatives":[{"name":"Competitor-informed product proof route","status":"implemented","owner":"Product strategy","buyerSegment":"Enterprise evaluators, investors, advisors, and sales reviewers","productSurface":"/competitive-intelligence","whyItImprovesScrimed":"It turns competitor analysis into an inspectable product surface that shows what SCRIMED will build, prove, and refuse to overclaim.","implementation":"Typed market sources, build patterns, initiatives, API route, and buyer-facing page.","proofRoute":"/api/competitive-intelligence","nextAction":"Keep sources reviewed monthly and tie each next build step to a sprint owner."},{"name":"Synthetic specialty bake-off packet","status":"package-next","owner":"Sales engineering","buyerSegment":"Clinical operations, documentation, revenue-cycle, and payer leaders","productSurface":"/pilot-deal-room","whyItImprovesScrimed":"It gives buyers a credible way to compare SCRIMED against incumbent categories without requiring live PHI or production connectors.","implementation":"No-PHI scorecard template using baseline metric, specialty scenario, evidence completeness, reviewer confidence, and governance blockers.","proofRoute":"/qa-evidence","nextAction":"Add a downloadable bake-off packet to the Pilot Deal Room after claim-guard review."},{"name":"Connector trust catalog","status":"package-next","owner":"Interoperability and security","buyerSegment":"CIO, CTO, security, procurement, and implementation teams","productSurface":"/integrations","whyItImprovesScrimed":"It answers the buyer's API, EHR, data, and security questions before a call becomes implementation ambiguity.","implementation":"Synthetic-ready, contract-ready, protected-gated, and blocked-live-use labels for each connector family.","proofRoute":"/interoperability","nextAction":"Attach trust labels to FHIR, HL7, X12, DICOM, SMART, and MCP fixture cards."},{"name":"PayerIQ evidence demo","status":"package-next","owner":"Revenue-cycle product","buyerSegment":"Payer operations, prior authorization, denials, appeals, and revenue integrity buyers","productSurface":"/agents/revenue-cycle-agent","whyItImprovesScrimed":"It gives SCRIMED a sharper wedge against revenue-cycle and payer platforms while staying review-gated.","implementation":"One synthetic scenario for policy evidence mapping, missing documentation detection, denial root-cause explanation, and appeal draft boundary.","proofRoute":"/workflows/results","nextAction":"Create a no-PHI scenario packet and route every financial-impact phrase through finance methodology gates."},{"name":"Healthcare intelligence OS layered pitch","status":"implemented","owner":"Founder and product marketing","buyerSegment":"Executives, board reviewers, public-sector partners, and strategic health systems","productSurface":"/strategic-intelligence","whyItImprovesScrimed":"It lets SCRIMED mirror the platform-level clarity of mature competitors while keeping a distinct governance-first category.","implementation":"Atlas context layer, AgentOS activation layer, TrustOS control layer, protected workspace boundary, and proof-packet release layer.","proofRoute":"/competitive-edge","nextAction":"Use this language in founder-led sales calls and keep claims aligned with the claims register."}],"targetAudienceStrategies":[{"slug":"health-system-executive-transformation-sponsors","priority":"immediate","targetAudience":"Health system executives and transformation sponsors","buyerRole":"CEO, COO, chief strategy officer, transformation office, enterprise innovation sponsor","competitorPressure":["Microsoft Dragon Copilot","Oracle Health","Abridge","Notable","Qventus"],"primaryPain":"Executive buyers see point solutions for notes, incumbent platform suites, and operations vendors, but still need a governed way to evaluate cross-functional AI before production risk expands.","scrimedCounterPosition":"Position SCRIMED as the healthcare intelligence operating layer that connects synthetic clinical, operational, revenue, safety, and governance proof without asking the buyer to replace an incumbent system.","offerMotion":"Executive no-PHI company assessment, workflow operating-loop demo, protected pilot deal room, then buyer-scoped enterprise pilot after approvals are defined.","proofRoutes":["/company-assessment","/competitive-intelligence","/pilot-demo-commercial-readiness","/pilot-deal-room"],"salesMessage":"SCRIMED helps leadership evaluate healthcare AI as an operating system, not another isolated tool, while keeping production authority, PHI, and customer proof release gated.","conversionTrigger":"Buyer asks for a multi-department pilot, executive scorecard, board-ready diligence packet, or cross-functional transformation roadmap.","strategicFollowThrough":"Package a 30-day executive assessment with three no-PHI workflow loops, one risk register, one buyer proof room, and a clear go/no-go production gate.","retainedBoundary":"Do not claim EHR replacement, enterprise transformation guarantee, customer-approved live deployment, clinical production readiness, or system-wide savings.","blockedClaims":["EHR replacement","unsupported system-wide savings assurance","customer-approved live deployment","clinical production ready"]},{"slug":"cmio-clinical-documentation-governance","priority":"immediate","targetAudience":"CMIO, clinical operations, documentation, and quality leaders","buyerRole":"CMIO, chief quality officer, nursing documentation leader, medical director, clinical informatics lead","competitorPressure":["Abridge","Ambience Healthcare","Nabla","Suki","Microsoft Dragon Copilot","Freed"],"primaryPain":"Ambient documentation is crowded, buyers expect fast relief, and clinical leaders need evidence quality, reviewer control, specialty fit, and downstream safety before trust scales.","scrimedCounterPosition":"Do not compete as a generic scribe. Sell SCRIMED as the evidence-governed clinical workflow layer that reviews documentation-adjacent outputs, attribution, exceptions, and downstream risk.","offerMotion":"Specialty bake-off scorecard, no-PHI documentation-adjacent demo, QA evidence review, and clinical-production-readiness gap map.","proofRoutes":["/demos","/evaluation","/qa-evidence","/clinical-production-readiness"],"salesMessage":"SCRIMED lets clinical leaders test whether AI work is explainable, reviewable, and safe to escalate before it touches live patients or records.","conversionTrigger":"Buyer asks how SCRIMED compares to an ambient scribe, whether specialty workflows can be evaluated, or how safety review is enforced.","strategicFollowThrough":"Create a specialty scorecard packet for each clinical demo with evidence completeness, reviewer confidence, exception handling, and blocked clinical claims.","retainedBoundary":"Do not claim autonomous note signing, diagnosis, treatment, certified specialty performance, clinical validation, or live PHI processing.","blockedClaims":["autonomous note signing","diagnosis or treatment authority","certified specialty performance","live PHI processing"]},{"slug":"revenue-cycle-payer-evidence-buyers","priority":"immediate","targetAudience":"Revenue-cycle, payer operations, prior authorization, denials, and appeals leaders","buyerRole":"VP revenue cycle, payer operations lead, utilization management leader, denials director, finance transformation sponsor","competitorPressure":["Commure","SmarterDx","Cohere Health","Notable"],"primaryPain":"Revenue and payer buyers need policy evidence, missing documentation visibility, denial-root-cause clarity, and financial controls without vendors overpromising reimbursement.","scrimedCounterPosition":"Position PayerIQ and Atlas as an evidence-first review engine for prior-auth support, denial-risk detection, appeal packet preparation, and finance-methodology discipline.","offerMotion":"No-PHI denial-risk and prior-auth evidence demo, finance review gate, buyer-defined metric baseline, then protected pilot packet.","proofRoutes":["/agents/revenue-cycle-agent","/workflows/results","/pricing","/public-market-readiness"],"salesMessage":"SCRIMED helps teams find payer friction and missing evidence before value leaks, while final coding, submission, and reimbursement decisions stay with qualified humans.","conversionTrigger":"Buyer asks for denial reduction, authorization acceleration, documentation specificity, or finance-backed impact evidence.","strategicFollowThrough":"Build a payer-evidence demo packet with policy references, missing evidence, denial reason taxonomy, appeal draft boundary, and finance signoff rule.","retainedBoundary":"Do not claim reimbursement assurance, automated payer approval, final coding decision, payment integrity certification, or claim submission authority.","blockedClaims":["unsupported reimbursement assurance","automated payer approval","final coding decision","claim submission authority"]},{"slug":"cio-cto-security-procurement","priority":"immediate","targetAudience":"CIO, CTO, CISO, security, procurement, and implementation teams","buyerRole":"CIO, CTO, CISO, security architect, procurement lead, integration lead, enterprise architect","competitorPressure":["Microsoft Dragon Copilot","Oracle Health","Nabla","Innovaccer","Notable"],"primaryPain":"Technical buyers need to know what is real, synthetic, contract-ready, blocked, or externally retained before they let AI vendors near data, identity, or EHR workflows.","scrimedCounterPosition":"Win with transparency: connector trust labels, API shape, identity and audit boundaries, protected workspace controls, and security/procurement evidence routing.","offerMotion":"Connector trust review, platform-power API/UI/AI review, enterprise scalability assessment, and protected buyer diligence room.","proofRoutes":["/interoperability","/trust-center","/platform-power","/enterprise-scalability","/pilot-workspace/access"],"salesMessage":"SCRIMED shows technical reviewers exactly which workflows are synthetic-ready, contract-ready, protected-gated, or blocked before implementation scope expands.","conversionTrigger":"Buyer asks for API documentation, EHR connector status, security review evidence, audit controls, SSO, data residency, or procurement questionnaire support.","strategicFollowThrough":"Attach connector trust labels and procurement evidence routing to each technical sales packet before any buyer-specific implementation statement is made.","retainedBoundary":"Do not claim certified EHR integration, approved security attestation, public API SLA, production PHI processing, or customer SSO readiness before approval.","blockedClaims":["certified EHR integration","unapproved security attestation","public API SLA","production PHI processing"]},{"slug":"community-independent-faith-clinics","priority":"near-term","targetAudience":"Independent, community, rural, and faith-based clinics","buyerRole":"Clinic owner, practice administrator, medical director, faith-based clinic sponsor, community health operator","competitorPressure":["Freed","Nabla","Suki","Abridge"],"primaryPain":"Smaller clinics want immediate relief and understandable pricing, but they may not have enterprise security teams, procurement staff, or appetite for complex platform sales cycles.","scrimedCounterPosition":"Offer a simple, mission-aware no-PHI readiness and workflow relief path that can graduate into protected pilots without pretending SCRIMED is already a live clinical system.","offerMotion":"Clinic readiness assessment, streamlined demo, starter pilot package, onboarding communications kit, and explicit affordability/margin guardrails.","proofRoutes":["/pricing","/pilot-demo-commercial-readiness","/investor-audience-readiness","/offerings","/client-onboarding"],"salesMessage":"SCRIMED gives clinics a practical path to evaluate safer healthcare AI without exposing patient data or committing to enterprise-scale implementation first.","conversionTrigger":"Buyer asks for a lower-cost pilot, mission-aligned service path, faith-based clinic package, or support preparing a donor or sponsor conversation.","strategicFollowThrough":"Create a clinic starter packet with one demo, one readiness checklist, one support cadence, one price band, and one external-review boundary page.","retainedBoundary":"Do not claim faith-based endorsement, donor advice, nonprofit tax advice, affordability assurance, clinical savings assurance, or live care authorization.","blockedClaims":["faith-based endorsement","donor or nonprofit tax advice","unsupported affordability assurance","live care authorization"]},{"slug":"investors-corporate-strategics","priority":"immediate","targetAudience":"Angel investors, private investors, corporate strategics, and board reviewers","buyerRole":"Angel investor, strategic corporate development lead, private investor, advisor, board reviewer","competitorPressure":["Hippocratic AI","Innovaccer","Microsoft Dragon Copilot","Notable","Commure"],"primaryPain":"Capital audiences compare SCRIMED against funded platforms with customer logos, incumbent infrastructure, and narrow category clarity, so SCRIMED needs proof of category focus and execution discipline.","scrimedCounterPosition":"Tell the healthcare intelligence OS story with evidence of product surfaces, readiness gates, commercial motions, moat signals, and no-overclaim discipline.","offerMotion":"Investor audience packet, capital vitality review, company assessment, competitive edge proof, and public-market readiness evidence map.","proofRoutes":["/investor-audience-readiness","/capital-vitality","/company-assessment","/competitive-edge","/public-market-readiness"],"salesMessage":"SCRIMED is building governed healthcare intelligence infrastructure with a safer proof ladder, not chasing hype without approval gates.","conversionTrigger":"Audience asks about moat, traction, revenue model, enterprise readiness, defensibility, clinical risk, or why SCRIMED can win against well-funded competitors.","strategicFollowThrough":"Maintain a capital packet that separates approved proof, readiness work, open gaps, blocked claims, and next investable milestones.","retainedBoundary":"Do not provide investment advice, securities offering material, solicitation, valuation assurance, audited financials, revenue guarantee, or acquisition implication.","blockedClaims":["securities offering","valuation assurance","revenue guarantee","acquisition interest"]},{"slug":"global-public-sector-regional-partners","priority":"protected","targetAudience":"Global partners, public-sector buyers, NGOs, and regional health systems","buyerRole":"Regional health buyer, public-sector sponsor, NGO partner, international procurement reviewer, localization lead","competitorPressure":["Oracle Health","Microsoft Dragon Copilot","Innovaccer","Cohere Health"],"primaryPain":"Global buyers need regional compliance posture, procurement pathway clarity, localization, data-transfer review, and trusted partner structure before adopting healthcare AI.","scrimedCounterPosition":"Lead with regional readiness packs, certification preparation, public-sector procurement questions, and partner-channel boundaries before any country-specific launch claim.","offerMotion":"Global reach pack, certification readiness review, approvals map, regional buyer packet, and external legal/privacy review gate.","proofRoutes":["/global-reach","/global-certification-readiness","/approvals-readiness","/trust-center"],"salesMessage":"SCRIMED can prepare a region-specific evaluation path while keeping regulatory approval, procurement authority, PHI, and live clinical execution outside the current product boundary.","conversionTrigger":"Buyer asks about GDPR, EU AI Act, NHS, MHRA, ISO, public-sector procurement, data residency, or regional partner deployment.","strategicFollowThrough":"Create a regional opportunity checklist with required approvals, partner role, data boundary, local counsel questions, and blocked public claims.","retainedBoundary":"Do not claim regional compliance approval, public-sector procurement approval, GDPR assurance, NHS/MHRA approval, ISO certification, or production authority.","blockedClaims":["regional compliance approval","public-sector procurement approval","GDPR assurance","NHS or MHRA approval"]},{"slug":"ai-platform-innovation-leaders","priority":"near-term","targetAudience":"AI platform, innovation, research, and transformation leaders","buyerRole":"Chief AI officer, innovation leader, research director, platform engineering lead, transformation architect","competitorPressure":["Hippocratic AI","Innovaccer","Notable","Microsoft Dragon Copilot"],"primaryPain":"Innovation leaders want agents, model routing, future-proofing, and research velocity, but they need governance that prevents unsafe production autonomy and public hype claims.","scrimedCounterPosition":"Sell AgentOS, TrustOS, evaluation loops, evidence retrieval, and internal research lanes, including quantum-safe readiness exploration, as governed innovation infrastructure.","offerMotion":"Platform Power review, continuous review and audit loop, AgentOS evaluation, TrustOS decision demo, and strategic intelligence roadmap.","proofRoutes":["/continuous-review-audit","/platform-power","/agent-os","/trust-os","/strategic-intelligence"],"salesMessage":"SCRIMED lets innovation teams move quickly on healthcare AI while every agent, claim, model route, and research theme stays reviewable and bounded.","conversionTrigger":"Buyer asks about agent workforces, model evaluation, model routing, future AI infrastructure, quantum-safe planning, or innovation governance.","strategicFollowThrough":"Keep future research internal until proof, approval, and security posture are defined; convert approved research into roadmap evidence only after review.","retainedBoundary":"Do not claim production model-routing approval, public quantum capability, autonomous clinical agents, model-safety certification, or clinical validation.","blockedClaims":["production model-routing approval","public quantum capability","autonomous clinical agents","model-safety certification"]},{"slug":"patient-access-contact-center-operations","priority":"near-term","targetAudience":"Patient access, contact center, operations, and throughput leaders","buyerRole":"Patient access director, contact center leader, operations VP, throughput leader, service-line administrator","competitorPressure":["Notable","Commure","Qventus"],"primaryPain":"Operations buyers want staffing relief, throughput visibility, patient access improvements, and reliable handoffs, but they cannot accept unsafe autonomous outreach or unsupported SLA claims.","scrimedCounterPosition":"Offer governed operational workflow templates that expose intake, agent suggestions, human approval, exception handling, and service delivery boundaries.","offerMotion":"Operations workflow demo, service-delivery work order, client onboarding cadence, operational-efficiency bottleneck review, and protected proof packet.","proofRoutes":["/workflows/results","/service-delivery","/client-onboarding","/operational-efficiency"],"salesMessage":"SCRIMED helps operations teams see where work slows down and how governed agents could help, without turning on autonomous patient contact or promising staffing reductions.","conversionTrigger":"Buyer asks about call-center automation, intake routing, discharge bottlenecks, scheduling friction, or operational throughput.","strategicFollowThrough":"Build a patient-access operating-loop demo with human approval, exception queue, handoff artifact, and support-capacity boundary.","retainedBoundary":"Do not claim autonomous patient outreach, staffing reduction assurance, managed 24/7 operations, contractual SLA, or production scheduling integration.","blockedClaims":["autonomous patient outreach","unsupported staffing reduction assurance","managed 24/7 operations","contractual SLA"]},{"slug":"clinical-governance-quality-safety-committees","priority":"immediate","targetAudience":"Clinical governance, quality, safety, and risk committees","buyerRole":"Clinical governance chair, quality committee, safety officer, risk manager, legal or compliance reviewer","competitorPressure":["Abridge","Hippocratic AI","Suki","SmarterDx","Microsoft Dragon Copilot"],"primaryPain":"Safety reviewers need proof that AI claims, workflow outputs, evidence attribution, escalation, and incident learning are controlled before pilots become live clinical programs.","scrimedCounterPosition":"Make TrustOS, QA Claim Guard, continuous review, and clinical production readiness the approval path for every clinical-adjacent claim and workflow.","offerMotion":"Clinical governance review packet, QA claim guard run, continuous audit loop, TrustOS decision demo, and clinical production task tracker.","proofRoutes":["/qa-claim-guard","/continuous-review-audit","/clinical-production-readiness","/trust-os"],"salesMessage":"SCRIMED is designed to show what it will not do yet, who must approve escalation, and how every clinical-adjacent output is reviewed before authority expands.","conversionTrigger":"Reviewer asks about patient safety, validation, escalation, incident response, human review, claims control, or clinical governance.","strategicFollowThrough":"Tie every clinical-facing pilot packet to QA Claim Guard, TrustOS evidence, clinical production readiness tasks, and incident-learning boundaries.","retainedBoundary":"Do not claim clinical validation complete, diagnostic authority, IRB approval, trial result proof, live clinical authority, or autonomous care.","blockedClaims":["clinical validation complete","diagnostic authority","IRB approval","autonomous care"]}],"nextBuildStep":"Package the executive assessment, specialty bake-off scorecard, connector trust catalog, PayerIQ evidence demo, clinic starter packet, and investor/global proof packets as audience-specific conversion routes."},"recommendedStrategicSequence":"Run the now bets first: buyer conversion compression, proof before production risk, and trust as procurement advantage. Then execute the customer-facing conversion command and no-PHI proof engine this week, deal desk, buyer proof release, and interoperability commands within 30 days, enterprise operating-layer and capital diligence commands within 60 days, and clinical/global approval runway within 90 days only when their decision gates are satisfied.","nextBuildStep":"Use the Strategic Execution Command Plan and Scorecards as the operating queue: run critical this-week commands first, require deal desk and proof-release discipline for 30-day expansion, package operating-layer and capital diligence motions within 60 days, and keep clinical/global approval work sequenced behind qualified review until evidence state improves."}